Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Open accessAbstract
Bipolar disorder (BPD) and schizophrenia (SZ) are severe psychiatric illnesses with a combined prevalence of 4%. A disturbance of energy metabolism is frequently observed in these disorders. Several pieces of evidence point to an underlying dysfunction of mitochondria: (i) decreased mitochondrial respiration; (ii) changes in mitochondrial morphology; (iii) increases in mitochondrial DNA (mtDNA) polymorphisms and in levels of mtDNA mutations; (iv) downregulation of nuclear mRNA molecules and proteins involved in mitochondrial respiration; (v) decreased high‐energy phosphates and decreased pH in the brain; and (vi) psychotic and affective symptoms, and cognitive decline in mitochondrial disorders. Furthermore, transgenic mice with mutated mitochondrial DNA polymerase show mood disorder‐like phenotypes. In this review, we will discuss the genetic and physiological components of mitochondria and the evidence for mitochondrial abnormalities in BPD and SZ. We will furthermore describe the role of mitochondria during brain development and the effect of current drugs for mental illness on mitochondrial function. Understanding the role of mitochondria, both developmentally as well as in the ailing brain, is of critical importance to elucidate pathophysiological mechanisms in psychiatric disorders.
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes evidence that mitochondrial dysfunction—decreased respiration, altered morphology, mtDNA changes, downregulated OXPHOS genes, and altered energy metabolites—is implicated in bipolar disorder (BPD) and schizophrenia (SZ). It argues that mitochondrial pathology may be primary in some cases or secondary to other factors, and that mood stabilizers may improve while some antipsychotics may impair mitochondrial function.
Key findings
- BPD and SZ, with a combined prevalence of approximately 4%, show disturbed energy metabolism and mitochondrial abnormalities including decreased mitochondrial respiration, changes in mitochondrial morphology, increased mtDNA polymorphisms/mutations, downregulation of nuclear-encoded mitochondrial mRNAs/proteins, and decreased high-energy phosphates and brain pH.
- Disease-associated mtDNA variants include 5178A>C (associated with lower frontal lobe pH), 3243A>G (impaired tRNA aminoacylation with compensatory LARS2 upregulation), 3644T>C (decreased mitochondrial membrane potential and complex I activity), and 10398A>G (decreased mitochondrial matrix pH, higher baseline and post-stimulation mitochondrial Ca2+, and greater prevalence in lithium nonresponders). The 5 kB “common deletion” was increased in cortex of BPD probands and suicide victims in one study but not associated in another frontal cortex study.
- Mitochondrial measures vary by brain region and cell type: rodent mtDNA copy numbers were 2,000–5,000 per cell in midbrain and striatum, ≥10,000 in spinal cord, striatum, and cortex, ~8,000 in medulla, and ≤4,000 in midbrain and cerebellum. Postmortem findings include smaller prefrontal cortex mitochondria in BPD, reduced oligodendrocyte mitochondrial numbers/volume in SZ prefrontal cortex, and fewer striatal mitochondria in SZ.
- In vivo MRS studies found reduced frontal lobe pH and phosphomonoester levels in BPD, and increased cerebrospinal fluid lactate and glucose in BPD indicating a shift from mitochondrial respiration to glycolysis. Rodent models with neuron-specific mutant POLG showed mood disorder-like phenotypes ameliorated by lithium or electroconvulsive shock; mood stabilizers lithium and valproate improved mitochondrial function/antiapoptotic markers, whereas typical antipsychotics inhibited complex I.
Methods
- Narrative review; no new experimental data were generated. The paper integrates genetic, physiological, postmortem, peripheral cell, imaging, and rodent studies relevant to mitochondrial function in BPD and SZ.
- Data/sample: published literature on patients with BPD and SZ, postmortem brain tissue, peripheral cells and cell lines, magnetic resonance spectroscopy in living patients, and animal models. Specific cited studies include, for example, 439 schizophrenia families for parent-of-origin analysis and MRS studies of medicated and unmedicated BPD patients.
- Main analysis: qualitative synthesis of evidence for mitochondrial abnormalities, mitochondrial genetics and physiology, oxidative stress, apoptosis, brain development, and effects of mood stabilizers and antipsychotics.
Limitations
- The paper states that evidence for a primary mitochondrial pathology in BPD and SZ is mixed, and that studies cannot differentiate primary pathologies from secondary consequences. It also notes that some MRS sample sizes were small, that common deletion levels are low and results inconsistent, and that mtDNA SNP associations vary by ancestry/haplogroup with no particular gene or region consistently targeted.
- Evident from the text: as a narrative review, it does not use a systematic search strategy or quantitative meta-analysis, and findings are drawn from heterogeneous tissues, populations, and study designs that are not directly comparable.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 163 cited sources checked · 0 supported · 0 flagged
- Premisecitation
First-generation antipsychotic drugs might have adverse effects on mitochondrial respiration.
“first-generation antipsychotic drugs might have adverse effects on mitochondrial respiration (Bachmann et al., 2009; King et al., 2001; Maurer and Moller, 1997; Maurer et al., 2009; Pereira et al., 1992; Prince et al., 1997b; Sagara, 1998; Struewing et al., 2007; Valvassori et al.; Washizuka et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bachmann et al., 2009
Not checked in the free run.
- cites King et al., 2001
Not checked in the free run.
- cites Maurer and Moller, 1997
Not checked in the free run.
- Premisecitation
A disturbance of energy metabolism is frequently observed in bipolar disorder and schizophrenia.
“A disturbance of energy metabolism is frequently observed in these disorders.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Cavelier et al., 1995
Not checked in the free run.
- cites Maurer et al., 2001
Not checked in the free run.
- cites Regenold et al., 2009
Not checked in the free run.
- Premisecitation
Abnormalities in energy metabolism in bipolar disorder and schizophrenia have been found in functional assays and magnetic resonance spectroscopy studies.
“Abnormalities in energy metabolism were found in functional assays (Cavelier et al., 1995; Maurer et al., 2001; Regenold et al., 2009) and in magnetic resonance spectroscopy studies (Dager et al., 2004; Deicken et al., 1995b; Frey et al., 2007; Jensen et al., 2006; Kato et al., 1993; Kato et al., 1995; Ongur et al., 2009; Stork and Renshaw, 2005; Yurgelun-Todd et al., 1996).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Cavelier et al., 1995
Not checked in the free run.
- cites Maurer et al., 2001
Not checked in the free run.
- cites Regenold et al., 2009
Not checked in the free run.
- Premisecitation
Gene and protein expression studies point to a decrease of factors and enzymes involved in ATP generation and storage in bipolar disorder and schizophrenia.
“Gene and protein expression studies point to a decrease of factors and enzymes involved in ATP generation and storage (Iwamoto et al., 2005; Karry et al., 2004; Klushnik et al., 1991; Konradi et al., 2004; MacDonald et al., 2006; Middleton et al., 2002; Mill et al., 2008; Pennington et al., 2008; Washizuka et al., 2005; Washizuka et al., 2009)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Iwamoto et al., 2005
Not checked in the free run.
- cites Karry et al., 2004
Not checked in the free run.
- cites Konradi et al., 2004
Not checked in the free run.
- Premisecitation
Linkage analysis showed an association of both bipolar disorder and schizophrenia with genes involved in mitochondrial function.
“linkage analysis showed an association of both disorders with genes involved in mitochondrial function (Kirk et al., 1999; Washizuka et al., 2003b; Washizuka et al., 2006; Xu et al., 2008; Zhang et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Kirk et al., 1999
Not checked in the free run.
- cites Washizuka et al., 2003b
Not checked in the free run.
- cites Xu et al., 2008
Not checked in the free run.
- Premisecitation
Mitochondrial structural abnormalities have been reported in patients with bipolar disorder.
“Mitochondrial structural abnormalities have been reported in patients with BPD (Cataldo et al.)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cataldo et al.
Not checked in the free run.
- Premisecitation
Mood stabilizers provide partial protection against mitochondrial toxicity.
“Mood stabilizers provide partial protection against mitochondrial toxicity, whereas first-generation antipsychotic drugs might have adverse effects on mitochondrial respiration (Bachmann et al., 2009; King et al., 2001; Maurer and Moller, 1997; Maurer et al., 2009; Pereira et al., 1992; Prince et al., 1997b; Sagara, 1998; Struewing et al., 2007; Valvassori et al.; Washizuka et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bachmann et al., 2009
Not checked in the free run.
- cites King et al., 2001
Not checked in the free run.
- cites Maurer and Moller, 1997
Not checked in the free run.
- Premisecitation
Both bipolar disorder and schizophrenia are associated with mitochondrial DNA mutations and polymorphisms.
“both diseases are associated with mitochondrial DNA (mtDNA) mutations and polymorphisms (Amar et al., 2007; Kato et al., 1997; Kato et al., 2000; Kato, 2001; Munakata et al., 2004; Munakata et al., 2005; Quiroz et al., 2008; Rollins et al., 2009; Shao et al., 2008; Ueno et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Amar et al., 2007
Not checked in the free run.
- cites Kato et al., 1997
Not checked in the free run.
- cites Munakata et al., 2004
Not checked in the free run.
- Premisecitation
Many survival factors and growth cues that determine whether a neuron will survive or die are affected by lithium.
“many survival factors and growth cues that determine whether a neuron will survive or die are affected by lithium, a mood stabilizer used to treat BPD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Machado-Vieira et al., 2009
Not checked in the free run.
- Premisecitation
Morphological changes of mitochondria have been observed in bipolar disorder and schizophrenia in brain tissue as well as peripheral tissue.
“Morphological changes of mitochondria have been observed in BPD and SZ in brain tissue as well as peripheral tissue.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Any mitochondrial pathology will have the most pronounced effect on the brain.
“Thus, any mitochondrial pathology will have the most pronounced effect on the brain.”
Quote in the paperSubstantial claim- Rests on an assumption: The brain depends exclusively on glycolysis and oxidative phosphorylation to create ATP.
- Premisecitation
The increases in cerebrospinal fluid lactate and glucose were not observed in schizophrenia patients in the same study.
“These changes were not observed in SZ patients in the same study, although peripheral blood mononuclear cells from first-onset, antipsychotic-naive SZ patients showed an increased expression of proteins associated with the glycolysis pathway after stimulation with staphylococcal enterotoxin (Herberth et al.).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Regenold et al., 2009
Not checked in the free run.
- Premisecitation
Rodent studies suggest that the reduction in cytochrome-c oxidase activity is not caused by treatment.
“Rodent studies suggest that this reduction is not caused by treatment (Prince et al., 1997a; Prince et al., 1997b).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Prince et al., 1997a
Not checked in the free run.
- cites Prince et al., 1997b
Not checked in the free run.
- Premisecitation
Schizophrenia patients had fewer mitochondria in the striatum than controls or individuals with other psychiatric diagnoses.
“SZ patients had also fewer mitochondria in the striatum than controls or individuals with other psychiatric diagnoses (Kung and Roberts, 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kung and Roberts, 1999
Not checked in the free run.
- Premisecitation
The cellular location of mitochondria was altered in lymphoblastoid and fibroblast cell lines of bipolar disorder patients.
“The cellular location of mitochondria was altered in lymphoblastoid and fibroblast cell lines of BPD patients (Cataldo et al.).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cataldo et al.
Not checked in the free run.
- Interpretationcitation
Dysregulation of the glycolysis pathway is in line with the increased prevalence of metabolic syndrome and insulin resistance observed in psychotic patients.
“Dysregulation of the glycolysis pathway is in line with the increased prevalence of metabolic syndrome and insulin resistance observed in psychotic patients (Regenold et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Regenold et al., 2002
Not checked in the free run.
- Premisecitation
The lack of histones and the limited proofreading ability of POLG causes a higher mutation rate in mitochondrial DNA relative to nuclear DNA.
“the lack of histones and the limited proofreading ability of POLG causes a higher mutation rate in mtDNA relative to nuclear DNA.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wallace, 2005
Not checked in the free run.
- Premisecitation
Psychiatric symptoms are frequently comorbid with mitochondrial disorders.
“psychiatric symptoms are frequently comorbid (Campos et al., 2001; Fattal et al., 2006; Grover et al., 2006; Mancuso et al., 2008; Prayson and Wang, 1998).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Campos et al., 2001
Not checked in the free run.
- cites Fattal et al., 2006
Not checked in the free run.
- cites Grover et al., 2006
Not checked in the free run.
- Premisecitation
Mononuclear cells of schizophrenia patients had enlarged mitochondria with fragmented cristae, independent of antipsychotic drug type used.
“Mononuclear cells of SZ patients had enlarged mitochondria with fragmented cristae, which was independent of antipsychotic drug type used (Inuwa et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Inuwa et al., 2005
Not checked in the free run.
- Premisecitation
Mitochondria were significantly smaller in the prefrontal cortex of bipolar disorder patients compared to normal controls.
“Mitochondria were significantly smaller in the prefrontal cortex (PFC) of BPD patients compared to normal controls. (Cataldo et al.).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cataldo et al.
Not checked in the free run.
- Premisecitation
Activated lymphocytes in individuals with schizophrenia had a lower mitochondrial density than controls.
“activated lymphocytes in individuals with SZ had a lower mitochondrial density than controls (Uranova et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Uranova et al., 2007
Not checked in the free run.
- Premisecitation
Peripheral blood mononuclear cells from first-onset, antipsychotic-naive schizophrenia patients showed an increased expression of proteins associated with the glycolysis pathway after stimulation with staphylococcal enterotoxin.
“peripheral blood mononuclear cells from first-onset, antipsychotic-naive SZ patients showed an increased expression of proteins associated with the glycolysis pathway after stimulation with staphylococcal enterotoxin (Herberth et al.).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Herberth et al.
Not checked in the free run.
- Premisecitation
Schizophrenia patients showed large reductions in cytochrome-c oxidase activity in the caudate nucleus, the frontal cortex and the temporal cortex.
“SZ patients showed large reductions in cytochrome-c oxidase activity in the caudate nucleus, the frontal cortex and the temporal cortex (Cavelier et al., 1995; Maurer et al., 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Cavelier et al., 1995
Not checked in the free run.
- cites Maurer et al., 2001
Not checked in the free run.
- Premisecitation
In the prefrontal cortex of schizophrenia patients, oligodendrocytes showed drastic reductions in mitochondrial numbers and volume.
“In the PFC of SZ patients, oligodendrocytes showed drastic reductions in mitochondrial numbers and volume (Uranova et al., 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Uranova et al., 2001
Not checked in the free run.
- Interpretationcitation
Low common deletion levels bring into question the impact of damaged DNA on brain function, since the prevailing intact mitochondrial DNA should be able to overcome the deleterious effects of mutant mitochondrial DNA.
“Low common deletion levels also bring into question the impact of damaged DNA on brain function, since the prevailing intact mtDNA should be able to overcome the deleterious effects of mutant mtDNA (McInerny et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites McInerny et al., 2009
Not checked in the free run.
- Interpretationcitation
Participants' ancestry may contribute to the variability in disease-associated mitochondrial DNA single nucleotide polymorphisms.
“Participants’ ancestry may contribute to the variability, as sites with disease-associated SNPs in one haplogroup may fail to be polymorphic in another (Kato, 2001; Shao et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kato, 2001
Not checked in the free run.
- cites Shao et al., 2008
Not checked in the free run.
- Premisecitation
Calcium homeostasis is impaired in both bipolar disorder and schizophrenia.
“Ca2+ homeostasis is impaired in both BPD and SZ.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Orrenius et al., 2003
Not checked in the free run.
- Premisecitation
Evidence for an increase in maternal parent-of-origin effect in psychiatric disorders is at best weak.
“evidence for an increase in maternal parent-of-origin effect in psychiatric disorders is at best weak (Kato et al., 1996; Lan et al., 2007; McMahon et al., 1995).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Kato et al., 1996
Not checked in the free run.
- cites Lan et al., 2007
Not checked in the free run.
- cites McMahon et al., 1995
Not checked in the free run.
- Premisecitation
A similar study of frontal cortex brains from individuals with bipolar disorder or schizophrenia failed to find an association with common deletion levels.
“In contrast, a similar study of frontal cortex brains from individuals with BPD or SZ failed to find an association with common deletion levels (Kakiuchi et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kakiuchi et al., 2005
Not checked in the free run.
- Premisecitation
Elevated calcium levels have been detected in peripheral cells from bipolar disorder and schizophrenia patients.
“Elevated Ca2+ levels have been detected in peripheral cells from BPD and SZ patients (Dubovsky et al., 1992; Kusumi et al., 1992; Ripova et al., 1997).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Dubovsky et al., 1992
Not checked in the free run.
- cites Kusumi et al., 1992
Not checked in the free run.
- cites Ripova et al., 1997
Not checked in the free run.
- Interpretationreasoning
Taken together, the data provide ample evidence for abnormalities in mitochondrial structure and function in bipolar disorder and schizophrenia.
“Taken together, the data provide ample evidence for abnormalities in mitochondrial structure and function in BPD and SZ.”
Quote in the paperSubstantial claim - Premisecitation
A polymorphism in the mt-ND1 gene which is associated with bipolar disorder, 3644T>C, causes decreased mitochondrial membrane potential and complex I activity.
“A polymorphism in the mt-ND1 gene which is associated with BPD, 3644T>C, causes decreased mitochondrial membrane potential and complex I activity (Munakata et al., 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Munakata et al., 2004
Not checked in the free run.
- Premisecitation
Peripheral blood mononuclear cells of bipolar disorder patients lacked the molecular response to glucose deprivation shown by cells of normal controls.
“Peripheral blood mononuclear cells of BPD patients lacked the molecular response to glucose deprivation shown by cells of normal controls (Naydenov et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Naydenov et al., 2007
Not checked in the free run.
- Premisecitation
Significant increases in the prevalence of the common deletion were found in the cortex of bipolar disorder probands and suicide victims.
“Significant increases in the prevalence of the common deletion were found in the cortex of BPD probands and suicide victims (Kato et al., 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kato et al., 1997
Not checked in the free run.
- Premisecitation
Lymphoblastoid cell lines derived from bipolar disorder patients show higher calcium peaks after thapsigargin, thrombin- or lysophosphatidic acid-mediated stimulation.
“Lymphoblastoid cell lines derived from BPD patients show higher Ca2+ peaks after thapsigargin, thrombin- or lysophosphatidic acid-mediated stimulation (Dubovsky et al., 1992; Kato et al., 2003; Ripova et al., 1997; Wasserman et al., 2004).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Dubovsky et al., 1992
Not checked in the free run.
- cites Kato et al., 2003
Not checked in the free run.
- cites Wasserman et al., 2004
Not checked in the free run.
- Premisecitation
Patients with the 5178A>C polymorphism, which is associated with bipolar disorder, tended to have lower frontal lobe pH compared to patients with 5178A when assayed by magnetic resonance spectroscopy.
“Patients with the 5178A>C polymorphism, which is associated with BPD, tended to have lower frontal lobe pH compared to patients with 5178A when assayed by MRS (Kato and Kato, 2000; Kato et al., 2000).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kato and Kato, 2000
Not checked in the free run.
- cites Kato et al., 2000
Not checked in the free run.
- Premisecitation
A 12027T>C variant observed in schizophrenia changes isoleucine to threonine in the mt-ND4 subunit of NADH-ubiquinone reductase.
“variant observed in SZ, 12027T>C results in the change from isoleucine to threonine of the mt-ND4 subunit of NADH-ubiquinone reductase (Marchbanks et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Marchbanks et al., 2003
Not checked in the free run.
- Premisecitation
Animal models of mutant DISC-1 have revealed that the protein localizes predominantly to mitochondria.
“Animal models of mutant DISC-1 have revealed that the protein localizes predominantly to mitochondria (James et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites James et al., 2004
Not checked in the free run.
- Premisecitation
A number of genes in the most commonly deleted area of 22q11.2 are important for mitochondrial function.
“A number of genes in the most commonly deleted area are important for mitochondrial function, such as the mitochondrial citrate transporter, the mitochondrial ribosomal protein MRPL40, proline dehydrogenase, thioredoxin reductase 2, and the zinc finger protein, ZDHHC8 (Maynard et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Maynard et al., 2008
Not checked in the free run.
- Premisecitation
Overexpression of truncated DISC-1 isoforms induced abnormal mitochondrial morphologies, indicating changes in mitochondrial dynamics such as fission and fusion.
“Overexpression of truncated DISC-1 isoforms induced abnormal mitochondrial morphologies, indicating changes in mitochondrial dynamics such as fission and fusion (Millar et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Millar et al., 2005
Not checked in the free run.
- Premisecitation
The 10398A>G SNP was found to be more prevalent in bipolar disorder patients that did not respond to lithium treatment.
“the 10398A>G SNP was found to be more prevalent in BPD patients that did not respond to lithium treatment (Washizuka et al., 2003a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Washizuka et al., 2003a
Not checked in the free run.
- Interpretationcitation
In studies of psychiatric patients, units of the electron transport chain have consistently shown reduced expression profiles.
“In studies of psychiatric patients, units of the electron transport chain have consistently shown reduced expression profiles.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Karry et al., 2004
Not checked in the free run.
- cites Konradi et al., 2004
Not checked in the free run.
- cites Altar et al., 2005
Not checked in the free run.
- Premisecitation
In the same study, complex I subunits were also decreased in the striatum.
“In the same study, complex I subunits were also decreased in the striatum.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karry et al., 2004
Not checked in the free run.
- Premisecitation
The effects of the 10398A>G polymorphism on mitochondrial matrix pH and calcium levels are tempered by the mood stabilizer valproic acid.
“Interestingly, the latter two effects are tempered by the mood stabilizer valproic acid (VPA) (Kato et al., 2003; Kazuno et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kato et al., 2003
Not checked in the free run.
- cites Kazuno et al., 2008
Not checked in the free run.
- Premisecitation
An mtDNA variant observed in schizophrenia, 12027T>C, results in the change from isoleucine to threonine of the mt-ND4 subunit of NADH-ubiquinone reductase.
“An mtDNA variant observed in SZ, 12027T>C results in the change from isoleucine to threonine of the mt-ND4 subunit of NADH-ubiquinone reductase (Marchbanks”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Marchbanks
Not checked in the free run.
- Premisecitation
In a gene expression study of the hippocampus, an extensive downregulation of genes involved in the electron transport chain was observed in bipolar disorder.
“In a gene expression study of the hippocampus, an extensive downregulation of genes involved in the electron transport chain was observed in BPD (Konradi et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Konradi et al., 2004
Not checked in the free run.
- Premisecitation
Velocardiofacial syndrome has a high incidence of psychotic symptoms.
“Velocardiofacial syndrome has a high incidence of psychotic symptoms (Arinami, 2006; Hercher and Bruenner, 2008; Ousley et al., 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Arinami, 2006
Not checked in the free run.
- cites Hercher and Bruenner, 2008
Not checked in the free run.
- cites Ousley et al., 2007
Not checked in the free run.
- Premisecitation
The G72/G30 locus is associated with schizophrenia and bipolar disorder.
“Another gene locus associated with SZ and BPD is G72/G30 (Bass et al., 2009; Boks et al., 2007; Chumakov et al., 2002; Hattori et al., 2003; Prata et al., 2008; Williams et al., 2006).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bass et al., 2009
Not checked in the free run.
- cites Boks et al., 2007
Not checked in the free run.
- cites Chumakov et al., 2002
Not checked in the free run.
- Premisecitation
A number of genetic risk factors for schizophrenia and bipolar disorder are associated with mitochondria and mitochondrial function.
“A number of genetic risk factor for SZ and BPD are associated with mitochondria and mitochondrial function.”
Quote in the paperSubstantial claim - Premisecitation
The 24-kDa and 51-kDa subunits of complex I were significantly decreased in the prefrontal cortex in schizophrenia.
“For example, the 24-kDa and 51-kDa subunits of complex I were significantly decreased in the PFC in SZ (Karry et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Karry et al., 2004
Not checked in the free run.
- Premisenone given
DISC-1 was identified in a large Scottish pedigree as a susceptibility gene for mental illness including schizophrenia and bipolar disorder.
“DISC-1, which encodes disrupted in schizophrenia 1, was identified in a large Scottish pedigree as a susceptibility gene for mental illness including SZ and BPD.”
Quote in the paperSubstantial claim - Premisecitation
In lymphoblastoid cell lines, the complex I gene NDUFV2 was downregulated in bipolar disorder type I but not type II.
“In lymphoblastoid cell lines, a complex I gene (NDUFV2) was downregulated in BPDI but not BPDII (Washizuka et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Washizuka et al., 2009
Not checked in the free run.
- Study design and conductcitation
Removing brain samples with lower pH removes all samples with mitochondrial pathologies.
“Removing samples with lower pH removes all samples with mitochondrial pathologies, as has been well demonstrated (Vawter et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vawter et al., 2006
Not checked in the free run.
- Premisecitation
Mice genetically modified to express mutant POLG specifically in neurons displayed increased startle response and altered circadian behavior.
“Mice that have been genetically modified to express mutant POLG specifically in neurons displayed increased startle response and altered circadian behavior (Kasahara et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kasahara et al., 2006
Not checked in the free run.
- Premisecitation
Treatments with the atypical antipsychotic clozapine did not alter complex I activity.
“Treatments with the atypical antipsychotic clozapine, however, did not alter complex I activity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Prince et al., 1997a
Not checked in the free run.
- Interpretationreasoning
Mitochondrial pathology may not be uniform across all brain regions and cell types.
“Mitochondrial pathology may not be uniform across all brain regions and cell types.”
Quote in the paperSubstantial claim - Interpretationreasoning
This suggests that antipsychotics might contribute to mitochondrial instability.
“This suggests that antipsychotics might contribute to mitochondrial instability.”
Quote in the paperSubstantial claim - Premisecitation
Increased PCr and decreased ATP levels in the right temporal lobe of schizophrenia patients correlate with positive symptom severity.
“In addition, increased PCr and decreased ATP levels in the right temporal lobe of SZ patients correlates with positive symptom severity (Deicken et al., 1995a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Deicken et al., 1995a
Not checked in the free run.
- Premisecitation
In the euthymic state, bipolar disorder participants showed reduced frontal lobe pH and PME levels compared to the manic state.
“In the euthymic state, participants showed reduced frontal lobe pH and PME levels as compared to the manic state.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kato et al., 1993
Not checked in the free run.
- Premisecitation
Both haloperidol and fluphenazine reduced complex I activity in striatum, frontal cortex, hippocampus, and cerebellum in rats.
“Both haloperidol and fluphenazine reduced complex I activity in striatum, frontal cortex, hippocampus, and cerebellum.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Prince et al., 1997a
Not checked in the free run.
- Premisecitation
Peripheral blood mononuclear cells of bipolar disorder patients failed to respond to glucose deprivation stress.
“Abnormalities were also found in peripheral blood mononuclear cells of BPD patients, which failed to respond to glucose deprivation stress (Naydenov et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Naydenov et al., 2007
Not checked in the free run.
- Premisecitation
The severity and degree of asymmetry of these frontal cortex abnormalities directly relates to performance on the prefrontal cortex-reliant Wisconsin Card Sorting Test in schizophrenia.
“The severity and degree of asymmetry of such abnormalities directly relates to performance on the PFC-reliant Wisconsin Card Sorting Test (Deicken et al., 1995c).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Deicken et al., 1995c
Not checked in the free run.
- Interpretationreasoning
Intra-individual differences between euthymia and mania point toward state-dependent mitochondrial abnormalities in bipolar disorder, rather than a predetermined pathology.
“The intra-individual differences between euthymia and mania point toward state-dependent mitochondrial abnormalities in BPD, rather than a predetermined pathology.”
Quote in the paperSubstantial claim - Interpretationnone given
Reduced mitochondrial viability and function causes decreased ATP production and reserves.
“Reduced mitochondrial viability and function causes decreased ATP production and reserves.”
Quote in the paperSubstantial claim - Premisecitation
In the ventral hippocampal rodent model of schizophrenia, reduced prefrontal cortex complex I protein levels were observed after puberty, but not before-a time course consistent with that of the onset of schizophrenia.
“In the ventral hippocampal rodent model of SZ, reduced PFC complex I protein levels were observed after puberty, but not before—a time course consistent with that of the onset of SZ (Ben-Shachar et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ben-Shachar et al., 2009
Not checked in the free run.
- Premisecitation
The degree of increase in complex I activity in platelets correlated directly with the severity of positive symptoms in schizophrenia.
“The degree of increase in complex I activity correlated directly with the severity of positive symptoms (Dror et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dror et al., 2002
Not checked in the free run.
- Premisecitation
The parieto-occipital cortex showed increased mRNA levels of selected complex I genes in bipolar disorder and schizophrenia.
“Moreover, the parieto-occipital cortex showed increased mRNA levels of selected complex I genes in BPD (Ben-Shachar and Karry, 2008) and SZ (Karry et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ben-Shachar and Karry, 2008
Not checked in the free run.
- cites Karry et al., 2004
Not checked in the free run.
- Premisecitation
Valproate and lithium normalized complex IV activity and caspase expression after a methamphetamine-induced insult.
“The drugs also normalized complex IV activity and caspase expression after a methamphetamine-induced insult (Bachmann et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bachmann et al., 2009
Not checked in the free run.
- Premisecitation
Kato et al. found reduced frontal lobe pH in medicated and unmedicated bipolar disorder patients.
“Kato et al. found reduced frontal lobe pH in medicated and unmedicated BPD patients (Kato et al., 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kato et al., 1998
Not checked in the free run.
- Interpretationreasoning
Advanced imaging techniques have revealed metabolic deficiencies in psychiatric patients that are consistent with the mitochondrial pathology seen in postmortem studies.
“The use of advanced imaging techniques has revealed metabolic deficiencies in psychiatric patients that are consistent with the mitochondrial pathology seen in postmortem studies.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mood stabilizers may alleviate some of the symptoms of bipolar disorder by improving mitochondrial function.
“This indicates that mood stabilizers may alleviate some of the symptoms of BPD by improving mitochondrial function.”
Quote in the paperSubstantial claim - Premisecitation
Two-dimensional proton echo-planar spectroscopic imaging of medication-free bipolar disorder patients in a depressed or mixed-mood state showed a shift from oxidative phosphorylation toward glycolysis.
“These data were further supported by two-dimensional proton echo-planar spectroscopic imaging of medication-free BPD patients in a depressed or mixed-mood state, which showed a shift from oxidative phosphorylation toward glycolysis (Dager et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dager et al., 2004
Not checked in the free run.
- Premisecitation
Therapeutic doses of valproate and lithium induced increases in mitochondrial oxygen consumption and mitochondrial membrane potential in the human neuroblastoma cell line SH-SY5Y.
“In the human neuroblastoma cell line, SH-SY5Y, therapeutic doses of VPA and lithium induced increases in mitochondrial oxygen consumption and mitochondrial membrane potential.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bachmann et al., 2009
Not checked in the free run.
- Interpretationcitation
The results support the notion that mutations in mitochondria-related nuclear genes can reproduce behaviors seen in psychiatric illness.
“The results support the notion that mutations in mitochondria-related nuclear genes can reproduce behaviors seen in psychiatric illness.”
Quote in the paperSubstantial claim- Rests on an assumption: Rodent behavioral abnormalities such as increased startle response and altered circadian behavior are valid analogues of human psychiatric symptoms.
- Interpretationreasoning
No matter where in the sequence of disease-causing events mitochondria might rank, mitochondrial pathology could be an important factor in the manifestation of clinical symptoms.
“No matter where in the sequence of disease-causing events mitochondria might rank, mitochondrial pathology could be an important factor in the manifestation of clinical symptoms.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Neurons with the highest energy demand are abnormal in bipolar disorder and schizophrenia.
“Thus, neurons with the highest energy demand are abnormal in BPD and SZ.”
Quote in the paperSubstantial claim
- May combine two claims. 47
- Classified as probably not a substantial claim. 7
May combine two claims.
InterpretationreasoningThe comorbidity and misdiagnosis of mitochondrial diseases with psychotic symptoms makes a strong case for a role of mitochondria in the clinical symptoms of psychosis.
“The latter observation makes a particularly strong case for a role of mitochondria in the clinical symptoms of psychosis, as the primary disease-causing event in mitochondrial disorders is the mtDNA mutation.”
Quote in the paperSubstantial claim- Rests on an assumption: The primary disease-causing event in mitochondrial disorders is the mitochondrial DNA mutation.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningDiseases caused by mitochondrial DNA mutations exhibit a matrilineal inheritance pattern.
“diseases caused by mtDNA mutations exhibit a matrilineal inheritance pattern (Shao et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shao et al., 2008
Not checked in the free run.
May combine two claims.
PremisecitationIn cerebrospinal fluid from bipolar disorder patients, lactate and glucose levels were increased, indicating a shift from mitochondrial respiration to glycolysis.
“In cerebrospinal fluid from BPD patients, lactate and glucose levels were increased, indicating a shift from mitochondrial respiration to glycolysis (Regenold et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Regenold et al., 2009
Not checked in the free run.
- Rests on an assumption: Impairment of oxidative phosphorylation activity causes accumulation of lactate and unprocessed glucose.
May combine two claims.
PremisecitationThe response to metabolic stress is impaired in bipolar disorder, and this impairment is closely linked to mitochondria.
“The response to metabolic stress is impaired in BPD, and this impairment is closely linked to mitochondria (Naydenov et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Naydenov et al., 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCommon symptoms of mitochondrial disease include seizure, blindness, diabetes, muscle weakness, and cardiomyopathy.
“Common symptoms of mitochondrial disease include seizure, blindness, diabetes, muscle weakness, and cardiomyopathy (DiMauro and Schon, 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites DiMauro and Schon, 2008
Not checked in the free run.
May combine two claims.
PremisecitationIn the prefrontal cortex of bipolar disorder patients, complex I activity was impaired and associated with increased protein oxidation and nitration.
“In the PFC of BPD patients, complex I activity was impaired and associated with increased protein oxidation and nitration (Andreazza et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Andreazza et al., 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMitochondria form microdomains with calcium influx sites to buffer cytosolic calcium.
“mitochondria form microdomains with calcium (Ca2+) influx sites to buffer cytosolic Ca2+ (Rizzuto and Pozzan, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rizzuto and Pozzan, 2006
Not checked in the free run.
May combine two claims.
PremisecitationAlthough antipsychotic drugs can contribute to abnormal glucose metabolism, increased insulin resistance is a hallmark of psychotic disorders.
“Although antipsychotic drugs can contribute to abnormal glucose metabolism (Newcomer, 2004), increased insulin resistance is a hallmark of psychotic disorders (Regenold et al., 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Newcomer, 2004
Not checked in the free run.
- cites Regenold et al., 2002
Not checked in the free run.
May combine two claims.
InterpretationcitationMitochondrial pathology in bipolar disorder and schizophrenia could be the consequence of genetic susceptibility, secondary to dysregulation of other neurotransmitter systems, or the result of environmental impacts such as exposure to toxins, famine, infections and substance abuse.
“Mitochondrial pathology could be the consequence of genetic susceptibility (Brandon et al., 2005b; Ishizuka et al., 2006; James et al., 2004; Kvajo et al., 2008; Millar et al., 2005; Stoffel et al., 1996), secondary to dysregulation of other neurotransmitter systems (Ben-Shachar, 2002; Brenner-Lavie et al., 2009; Chen et al., 2008) or the results of environmental impacts such as exposure to toxins”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Brandon et al., 2005b
Not checked in the free run.
- cites Ben-Shachar, 2002
Not checked in the free run.
- cites Brown and Derkits
Not checked in the free run.
May combine two claims.
PremisecitationLymphocytes of bipolar disorder patients failed to respond to glucose deprivation while lymphocytes of normal controls responded with an upregulation of the elements of the electron transport chain.
“Lymphocytes of BPD patients failed to respond to glucose deprivation while lymphocytes of normal controls responded with an upregulation of the elements of the electron transport chain (Naydenov et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Naydenov et al., 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDetrimental mitochondrial mutations impair the effectiveness of oxidative phosphorylation, and highly oxidative-phosphorylation-reliant tissues such as the brain, pancreas, and muscle are more commonly affected.
“Detrimental mitochondrial mutations impair the effectiveness of OXPHOS, and highly OXPHOS-reliant tissues such as the brain, pancreas, and muscle are more commonly affected (Wallace, 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wallace, 2005
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMitochondrial DNA mutations accumulate throughout a lifetime, while mitochondrial DNA levels and mitochondrial function tend to decline with age.
“Mitochondrial DNA mutations accumulate throughout a lifetime, while mtDNA levels and mitochondrial function tend to decline with age (Wallace, 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wallace, 2005
Not checked in the free run.
May combine two claims.
PremisecitationThe common deletion occurs at low rates in non-diseased tissues and tends to increase in prevalence with age.
“This deletion is one of the more prevalent mtDNA alterations, but occurs at low rates in non-diseased tissues and tends to increase in prevalence with age (Brandon et al., 2005a; Fuke et al., 2008; McInerny et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Brandon et al., 2005a
Not checked in the free run.
- cites Fuke et al., 2008
Not checked in the free run.
- cites McInerny et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAt baseline, roughly 1-5% of all oxygen consumed by the cell is converted to reactive oxygen species.
“At baseline, roughly 1-5% of all oxygen consumed by the cell is converted to ROS (Lee and Wei, 2005)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee and Wei, 2005
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMitochondrial calcium overload can have detrimental effects on mitochondrial viability and ultimately causes cell death.
“Mitochondrial Ca2+ overload, however, can have detrimental effects on mitochondrial viability and ultimately causes cell death (Orrenius et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Orrenius et al., 2003
Not checked in the free run.
May combine two claims.
PremisecitationCells with high levels of the common deletion produce more reactive oxygen species when stimulated with an H2O2 insult, resulting in reduced cell viability.
“the cells with high levels of this common deletion produce more reactive oxygen species when stimulated with an H2O2 insult, resulting in reduced cell viability (Jou et al., 2005; Liu et al., 2007; Wang and Lu, 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Jou et al., 2005
Not checked in the free run.
- cites Liu et al., 2007
Not checked in the free run.
- cites Wang and Lu, 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased glutamate release during emotional situations and drug use, or decreased glucose levels during times of famine or deliberate starvation, are known risk factors for psychotic episodes.
“These factors are known risk factors for psychotic episodes (Brown and Derkits; Brown and Yamamoto, 2003; Kroll, 2007; Kyle and Pichard, 2006)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Brown and Derkits
Not checked in the free run.
- cites Brown and Yamamoto, 2003
Not checked in the free run.
- cites Kroll, 2007
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe combination of elevated calcium levels and decreased ATP production will cause continuous cellular stress and reduce the ability to appropriately respond to temporary peaks in stressful stimuli such as increased glutamate release during emotional situations and drug use, or decreased glucose levels during times of famine or deliberate starvation.
“The combination of elevated Ca2+ levels and decreased ATP production will cause continuous cellular stress and reduce the ability to appropriately respond to temporary peaks in stressful stimuli such as increased glutamate release during emotional situations and drug use, or decreased glucose levels during times of famine or deliberate starvation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe data suggest that mitochondrial DNA mutations in bipolar disorder and schizophrenia might be somatic rather than inherited, indicating either an overall increased vulnerability of mitochondrial DNA, or a higher exposure to DNA-damaging factors.
“The data suggest that mtDNA mutations in BPD and SZ might be somatic rather than inherited, indicating either an overall increased vulnerability of mtDNA, or a higher exposure to DNA-damaging factors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLarge family studies have revealed increased rates of bipolar disorder and schizophrenia within families, suggesting a genetic vulnerability.
“Large family studies have revealed increased rates of BPD and SZ within families, suggesting a genetic vulnerability (Gershon et al., 1982).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gershon et al., 1982
Not checked in the free run.
May combine two claims.
InterpretationcitationBipolar disorder mitochondria fail to maintain ATP output, which could heighten their sensitivity to mild insults.
“BPD mitochondria fail to maintain ATP output, which could heighten their sensitivity to mild insults. (Plant et al., 2002)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Plant et al., 2002
Not checked in the free run.
May combine two claims.
PremisecitationIn a group of 439 families affected by schizophrenia, rates of maternal and paternal inheritance patterns were roughly equal, and 52% of the families investigated had ill relatives on both sides of the family.
“In a group of 439 families affected by SZ, rates of maternal and paternal inheritance patterns were roughly equal, and 52% of the families investigated had ill relatives on both sides of the family (DeLisi et al., 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites DeLisi et al., 2000
Not checked in the free run.
May combine two claims.
PremisecitationThe percentage of mitochondrial DNA that contains the common deletion is quite low, which might make it difficult to obtain consistent results.
“The percentage of mtDNA that contains the common deletion is quite low, which might make it difficult to obtain consistent results (McInerny et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites McInerny et al., 2009
Not checked in the free run.
May combine two claims.
InterpretationreasoningDue to mosaicism, deletion levels can vary even between adjacent tissues and the results might not accurately reflect a potential pathology.
“However, due to mosaicism, deletion levels can vary even between adjacent tissues and the results might not accurately reflect a potential pathology.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMicroarray analysis of peripheral blood mononuclear cells revealed that controls upregulated expression of electron transport genes in response to glucose deprivation, while cells from bipolar disorder patients failed to show any changes in mitochondrial gene expression.
“Microarray analysis of the peripheral blood mononuclear cells revealed that controls upregulated expression of electron transport genes in response to glucose deprivation, while cells from BPD patients failed to show any changes in mitochondrial gene expression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Naydenov et al., 2007
Not checked in the free run.
May combine two claims.
PremisecitationThe schizophrenia- and bipolar-disorder-associated SNP 3243A>G, which lies in a leucine-tRNA gene, hampers the tRNA's aminoacylation, resulting in a compensatory upregulation of the leucyl-tRNA synthetase LARS2 that is seen both in cybrids containing 3243A>G and patient brains.
“The SZ- and BPD-associated SNP 3243A>G, which lies in a leucine-tRNA gene, hampers the tRNA’s aminoacylation, resulting in a compensatory upregulation of the leucyl-tRNA synthetase LARS2 that is seen both in cybrids containing 3243A>G and patient brains (Munakata et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Munakata et al., 2005
Not checked in the free run.
May combine two claims.
PremisecitationMost groups identified different mitochondrial DNA single nucleotide polymorphisms across the mitochondrial genome as having disease associations, and no particular gene or region of mitochondrial DNA appears to be targeted.
“Most groups identified different SNPs across the mitochondrial genome as having disease associations, and no particular gene or region of mtDNA appears to be targeted.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Amar et al., 2007
Not checked in the free run.
- cites Kato et al., 2000
Not checked in the free run.
- cites Munakata et al., 2004
Not checked in the free run.
May combine two claims.
InterpretationreasoningIn the cerebellum, a similar pattern of complex I subunit expression was observed, indicating that impairments in mitochondrial function may be widespread in individuals with these disorders.
“In the cerebellum, a similar pattern of expression was observed, indicating that impairments in mitochondrial function may be widespread in individuals with these disorders.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationReductions in complex I protein expression correlate with reduced complex I function and increased protein oxidation and nitrosylation.
“Reductions in complex I protein expression have also been found to correlate with reduced complex I function as well as increased protein oxidation and nitrosylation (Andreazza et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Andreazza et al., 2010
Not checked in the free run.
May combine two claims.
InterpretationcitationWhile evidence for a primary mitochondrial pathology in bipolar disorder and schizophrenia is mixed, evidence for psychotic and mood disorder symptoms in bona fide mitochondrial disorders is quite strong.
“While the evidence for a primary mitochondrial pathology in BPD and SZ is mixed, the evidence for psychotic and mood disorder symptoms in bona fide mitochondrial disorders is quite strong”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Campos et al., 2001
Not checked in the free run.
- cites Fattal et al., 2006
Not checked in the free run.
- cites Grover et al., 2006
Not checked in the free run.
May combine two claims.
InterpretationcitationMagnetic resonance spectroscopy studies of living patients circumvent the problem of low pH in postmortem samples and further support a link between brain pH and altered energy metabolism.
“Magnetic resonance spectroscopy studies of living patients circumvent the problem of low pH in postmortem samples, and further support the notion of a link between brain pH and altered energy metabolism”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Dager et al., 2004
Not checked in the free run.
- cites Kato et al., 1993
Not checked in the free run.
- cites Kato et al., 1998
Not checked in the free run.
May combine two claims.
PremisecitationThe bipolar-disorder-associated 10398A>G polymorphism has been linked to decreased mitochondrial matrix pH, and higher baseline and post-stimulation mitochondrial calcium levels.
“The BPD-associated 10398A>G polymorphism has been linked to decreased mitochondrial matrix pH, and higher baseline and post-stimulation mitochondrial Ca2+ levels (Kato and Kato, 2000; Kato et al., 2003; Kazuno et al., 2006; Kazuno et al., 2008; Washizuka et al., 2003a).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Kato and Kato, 2000
Not checked in the free run.
- cites Kato et al., 2003
Not checked in the free run.
- cites Kazuno et al., 2006
Not checked in the free run.
May combine two claims.
InterpretationcitationDisease-associated mutations in nuclear complex I genes have been identified and could contribute to observed reductions in complex I mRNA and protein expression levels.
“Disease-associated mutations in nuclear complex I genes have been identified, for example, and could contribute to observed reductions in complex I mRNA and protein expression levels”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Andreazza et al., 2010
Not checked in the free run.
- cites Ben-Shachar and Karry, 2008
Not checked in the free run.
- cites Karry et al., 2004
Not checked in the free run.
May combine two claims.
PremisecitationSimilar downregulation of electron transport chain genes was observed in the hippocampus in schizophrenia, and downregulation of TCA cycle genes was observed in the prefrontal cortex.
“Similar observations were made in the hippocampus in SZ (Altar et al., 2005), and a downregulation of TCA cycle genes was observed in the PFC (Middleton et al., 2002).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Altar et al., 2005
Not checked in the free run.
- cites Middleton et al., 2002
Not checked in the free run.
May combine two claims.
InterpretationreasoningMitochondria are important factors of consideration in psychiatric disorders, though they might not necessarily be the primary cause.
“The data demonstrate that mitochondria are important factors of consideration in psychiatric disorders, though they might not necessarily be the primary cause for these disorders.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe G72 protein localizes to mitochondria, and its overexpression can alter mitochondrial morphology by enhancing mitochondrial fragmentation.
“The G72 protein localizes to mitochondria, and its overexpression can alter mitochondrial morphology by enhancing mitochondrial fragmentation (Kvajo et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kvajo et al., 2008
Not checked in the free run.
May combine two claims.
PremisecitationLevels of creatine kinase mRNA were downregulated in the hippocampus and prefrontal cortex in bipolar disorder and schizophrenia, indicating altered energy metabolism.
“It is thus not surprising that levels of creatine kinase mRNA were downregulated in the hippocampus and PFC in BPD and SZ (MacDonald et al., 2006), another indication of altered energy metabolism.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites MacDonald et al., 2006
Not checked in the free run.
May combine two claims.
InterpretationcitationComparison of medicated to unmedicated bipolar disorder patients revealed no significant difference in brain pH, suggesting mood stabilizers do not affect brain pH.
“Although the sample size was small, comparison of medicated to unmedicated patients revealed no significant difference in brain pH, suggesting that mood stabilizers do not affect brain pH.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kato et al., 1998
Not checked in the free run.
May combine two claims.
InterpretationreasoningA large number of studies have shown that the overall stability of mitochondria, the efficiency of OXPHOS, and the ability to buffer Ca2+ and neutralize ROS are affected in bipolar disorder and schizophrenia.
“A large number of studies have shown that the overall stability of mitochondria, the efficiency of OXPHOS, and the ability to buffer Ca2+ and neutralize ROS, are affected in BPD and SZ.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThese behaviors were ameliorated by lithium treatment as well as by electroconvulsive shock treatment.
“These behaviors were ameliorated by lithium treatment as well as by electroconvulsive shock treatment (Kasahara et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kasahara et al., 2008
Not checked in the free run.
May combine two claims.
InterpretationreasoningWhile many of these disturbances could be secondary to lifestyle and drug treatment, evidence from animal and genetic studies indicates that in some cases mitochondrial pathology might be the primary cause.
“While many of these disturbances could be secondary to lifestyle and drug treatment, evidence from animal and genetic studies indicates that in some cases mitochondrial pathology might be the primary cause.”
Quote in the paperSubstantial claim- Rests on an assumption: Rodent behavioral abnormalities such as increased startle response and altered circadian behavior are valid analogues of human psychiatric symptoms.
May combine two claims.
PremisecitationSchizophrenia patients exhibit markers of increased lipid breakdown in frontal cortex, with increased PDEs in both frontal hemispheres and reduced PMEs in left frontal cortex.
“Likewise, SZ patients exhibit markers of increased lipid breakdown in frontal cortex, with increased PDEs in both frontal hemispheres, and reduced PMEs in left frontal cortex.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Deicken et al., 1995c
Not checked in the free run.
May combine two claims.
InterpretationreasoningAlthough these studies cannot differentiate primary pathologies from secondary consequences, it is quite likely that mitochondrial pathologies are responsible for some of the symptoms observed in bipolar disorder and schizophrenia.
“Although these studies cannot differentiate primary pathologies from secondary consequences, it is quite likely that mitochondrial pathologies are responsible for some of the symptoms observed in BPD and SZ.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationReduced PME and increased PDE levels were observed in the frontal cortex in bipolar disorder and schizophrenia patients, indicating increased lipid breakdown in the brain.
“Reduced PME and increased phosphodiester (PDE) levels were observed in the frontal cortex in BPD and SZ patients, indicating increased lipid breakdown in the brain”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Deicken et al., 1995b
Not checked in the free run.
- cites Fujimoto et al., 1992
Not checked in the free run.
- cites Klemm et al., 2001 source
Not checked in the free run.
May combine two claims.
InterpretationcitationAntipsychotic drugs do not improve the mitochondrial pathology observed in schizophrenia, and some of these drugs inhibit complex I activity.
“Antipsychotic drugs do not improve the mitochondrial pathology observed in SZ, and some of these drugs inhibit complex I activity.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningWith little ATP reserves, stressful situations or periods of decreased glucose availability could cause severe malfunctions, explaining known risk factors for affective disorders and schizophrenia.
“Furthermore, with little ATP reserves (such a PCr) stressful situations or periods of decreased glucose availability could cause severe malfunctions, explaining known risk factors for affective disorders and SZ”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Brown and Derkits, 2010
Not checked in the free run.
- cites Brown and Yamamoto, 2003
Not checked in the free run.
- cites Kroll, 2007
Not checked in the free run.
May combine two claims.
PremisecitationIn rat liver, typical, but not atypical, antipsychotics inhibited complex I activity and facilitated activity of complex IV.
“In rat liver, typical, but not atypical, antipsychotics inhibited complex I activity and facilitated activity of complex IV (Modica-Napolitano et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Modica-Napolitano et al., 2003
Not checked in the free run.
May combine two claims.
PremisecitationIn contrast to brain studies, complex I activity and expression of the 24- and 51-kDa iron-sulfur flavoprotein subunits were increased in platelets of schizophrenia patients, with no change in bipolar disorder patients.
“In contrast to the various studies reporting a downregulation of mitochondrial genes in the brain, complex I activity and expression of the 24- and 51-kDa iron-sulfur flavoprotein subunits were increased in platelets of SZ patients, with no change in BPD patients (Ben-Shachar et al., 1999; Dror et al., 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ben-Shachar et al., 1999
Not checked in the free run.
- cites Dror et al., 2002
Not checked in the free run.
May combine two claims.
PremisecitationBipolar disorder patients exhibited a reduction and a left-right asymmetry in PCr levels that was not seen in controls, suggesting abnormalities in either the production or maintenance of high-energy phosphates.
“BPD patients also exhibited a reduction and a left-right asymmetry in PCr levels that was not seen in controls, suggesting that BPD patients have abnormalities in either the production or maintenance of high-energy phosphates”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Deicken et al., 1995b
Not checked in the free run.
- cites Kato et al., 1994
Not checked in the free run.
May combine two claims.
PremisecitationLithium increased the activity of electron transport chain complexes I, II and III in homogenates of the human prefrontal cortex, while a slight reduction was seen in complex IV activity at very high drug doses.
“Lithium increased the activity of electron transport chain complexes I, II and III in homogenates of the human PFC, while a slight reduction was seen in complex IV activity at very high drug doses (Maurer et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Maurer et al., 2009
Not checked in the free run.
May combine two claims.
PremisecitationBoth typical and atypical antipsychotic drugs increased complex IV activity in frontal cortex, but only atypical antipsychotic drugs increased complex IV activity in the hippocampus.
“Both typical and atypical antipsychotic drugs increased complex IV activity in frontal cortex, but only atypical antipsychotic drugs increased complex IV activity in the hippocampus.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Prince et al., 1997a
Not checked in the free run.
The paper relies on this without support.
The primary disease-causing event in mitochondrial disorders is the mitochondrial DNA mutation.
“as the primary disease-causing event in mitochondrial disorders is the mtDNA mutation.”
The paper relies on this without support.
The brain depends exclusively on glycolysis and oxidative phosphorylation to create ATP.
“Unlike most other tissues, the brain depends exclusively on glycolysis and OXPHOS to create ATP.”
The paper relies on this without support.
Impairment of oxidative phosphorylation activity causes accumulation of lactate and unprocessed glucose.
“Impairment of OXPHOS activity causes accumulation of lactate and unprocessed glucose (figure 2A).”
The paper relies on this without support.
Rodent behavioral abnormalities such as increased startle response and altered circadian behavior are valid analogues of human psychiatric symptoms.
“The results support the notion that mutations in mitochondria-related nuclear genes can reproduce behaviors seen in psychiatric illness.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Broad mitochondrial dysfunctions have been reported in the context of ROS and RNS overproduction in bipolar disorder.
“Broad mitochondrial dysfunctions have also been reported in the context of ROS and RNS overproduction described in BD.”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Schizophrenia lactate finding contradicts the cited study's title
MinorThe text says the increased cerebrospinal-fluid lactate and glucose levels were not observed in schizophrenia patients in the same study. The cited study's title explicitly reports elevated cerebrospinal-fluid lactate in patients with schizophrenia, contradicting at least the lactate portion of that statement.
“In cerebrospinal fluid from BPD patients, lactate and glucose levels were increased, indicating a shift from mitochondrial respiration to glycolysis (Regenold et al., 2009). These changes were not observed in SZ patients in the same study”
“Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis”
Cites
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · see citing works
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060 · see citing works
Regulation of cell death: the calcium–apoptosis link
Orrenius, S., Zhivotovsky, B., & Nicotera, P. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1150 · Cited by 3,013 · see citing works
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650 · see citing works
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269 · see citing works
Microdomains of Intracellular Ca2+: Molecular Determinants and Functional Consequences
Rizzuto, R., & Pozzan, T. (2005) · Physiological Reviews · doi:10.1152/physrev.00004.2005 · Cited by 1,201 · see citing works
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163 · see citing works
Hotchkiss, R. S., Strasser, A., McDunn, J. E., & Swanson, P. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0901217 · Cited by 1,150 · see citing works
A Family Study of Schizoaffective, Bipolar I, Bipolar II, Unipolar, and Normal Control Probands
Gershon, E. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290100031006 · Cited by 987 · see citing works
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
Chipuk, J. E., & Green, D. R. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.007 · Cited by 982 · see citing works
Mitochondrial transcription factor A regulates mtDNA copy number in mammals
Ekstrand, M. I. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh109 · Cited by 919 · see citing works
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. M. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880 · see citing works
Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis
Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.008 · Cited by 773 · see citing works
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress
Lee, H., & Wei, Y. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.010 · Cited by 660 · see citing works
MITOMAP: a human mitochondrial genome database--2004 update
Brandon, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki079 · Cited by 568 · see citing works
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., Rosa, P. L., et al. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.182412499 · Cited by 541 · see citing works
Mitochondrial Disorders in the Nervous System
DiMauro, S., & Schon, E. A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094302 · Cited by 536 · see citing works
Psychiatric genetics: progress amid controversy
Burmeister, M., McInnis, M. G., & Zöllner, S. K. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2381 · Cited by 522 · see citing works
High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons
Russell, J. W., Golovoy, D., Vincent, A. M., Mahendru, P., Olzmann, J. A., Mentzer, A., & Feldman, E. L. (2002) · The FASEB Journal · doi:10.1096/fj.01-1027com · Cited by 520 · see citing works
Number matters: control of mammalian mitochondrial DNA copy number
Montier, L., Deng, J., & Bai, Y. (2009) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60099-5 · Cited by 513 · see citing works
Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
Konradi, C. L., Eaton, M. E., MacDonald, M. L., Walsh, J. P., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 499 · see citing works
Self-citationIwamoto, K., Bundo, M., & Kato, T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi022 · Cited by 496 · see citing works
Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology
Craddock, N. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj033 · Cited by 496 · see citing works
Electron microscopy of oligodendroglia in severe mental illness
Uranova, N., Orlovskaya, D., Vikhreva, O., Zimina, I., Kolomeets, N., Vostrikov, V., & Rachmanova, V. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00528-7 · Cited by 495 · see citing works
Stork, C., & Renshaw, P. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001711 · Cited by 486 · see citing works
Pettegrew, J. W. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810300075011 · Cited by 482 · see citing works
22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia
Karayiorgou, M., Simon, T. J., & Gogos, J. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2841 · Cited by 474 · see citing works
Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
Chen, R., & Chuang, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 470 · see citing works
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470 · see citing works
Brain Metabolic Alterations in Medication-Free Patients With BipolarDisorder
Dager, S. R., Friedman, S. D., Parow, A. M., Demopulos, C. M., Stoll, A. L., Lyoo, I. K., Dünner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 453 · see citing works
Andreazza, A. C., Shao, L., Wang, J.-F., & Young, L. T. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.22 · Cited by 448 · see citing works
Silva, J. P., Köhler, M., Graff, C., Oldfors, A., Magnuson, M. A., Berggren, P.-O., & Larsson, N.-G. (2000) · Nature Genetics · doi:10.1038/81649 · Cited by 433 · see citing works
Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., & Levitt, P. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02718.2002 · Cited by 428 · see citing works
Mitochondrial membrane permeabilization in neuronal injury
Galluzzi, L., Blomgren, K., & Kroemer, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2665 · Cited by 418 · see citing works
Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria.
Murphy, A. N., Bredesen, D. E., Cortopassi, G. A., Wang, E., & Fiskum, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9893 · Cited by 403 · see citing works
Mechanisms and consequences of somatic mosaicism in humans
Youssoufian, H., & Pyeritz, R. E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg906 · Cited by 391 · see citing works
Mitochondrial dysfunction in bipolar disorder
Kato, T., & Kato, N. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020305.x · Cited by 381 · see citing works
Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00714.x · Cited by 370 · see citing works
The functional organization of mitochondrial genomes in human cells
Iborra, F. J., Kimurâ, H., & Cook, P. R. (2004) · BMC Biology · doi:10.1186/1741-7007-2-9 · Cited by 339 · see citing works
Liu, H., Heath, S. C., Sobin, C., Roos, J. L., Galke, B. L., Blundell, M. L., Lenane, M., Robertson, B., Wijsman, E. M., Rapoport, J. L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042700699 · Cited by 323 · see citing works
Heckers, S., Stone, D., Walsh, J., Shick, J., Koul, P., & Benes, F. M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.521 · Cited by 322 · see citing works
Altar, C. A., Jurata, L. W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., Young, T. A., Bullard, J., Yokoe, H., Webster, M. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.031 · Cited by 318 · see citing works
Mitochondrial involvement in psychiatric disorders
Shao, L., Martin, M. V., Watson, S. J., Schatzberg, A. F., Akil, H., Myers, R., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2008) · Annals of Medicine · doi:10.1080/07853890801923753 · Cited by 303 · see citing works
Increased mitochondrial mass in mitochondrial myopathy mice
Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H. H., Burden, S. J., Oldfors, A., Westerblad, H., & Larsson, N.-G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232591499 · Cited by 302 · cited 2× · see citing works
“…by which mtDNA copy number is regulated is not yet known, but TFAM is thought to play a role in this process, as TFAM knockout mice show mtDNA depletion, resulting in deficient electron transport and ATP synthesis, and the development of myopathy (Silva et al., 2000; Wredenberg et al., 2002).”
BackgroundRegenold, W. T. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00456-6 · Cited by 293 · see citing works
Molecular Mechanisms of Schizophrenia
Lang, U. E., Puls, I., Müller, D. J., Strutz‐Seebohm, N., & Gallinat, J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110430 · Cited by 281 · see citing works
Abnormalities in Mitochondrial Structure in Cells from Patients with Bipolar Disorder
Cataldo, A. M., McPhie, D. L., Lange, N. T., Punzell, S., Elmiligy, S., Ye, N. Z., Froimowitz, M. P., Hassinger, L. C., Menesale, E. B., Sargent, L. W., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.081068 · Cited by 269 · see citing works
Subtyping schizophrenia: implications for genetic research
Jablensky, A. V. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001857 · Cited by 267 · see citing works
Hattori, E., Liu, C., Badner, J. A., Bonner, T. I., Christian, S. L., Maheshwari, M., Detera‐Wadleigh, S. D., Gibbs, R. A., & Gershon, E. S. (2003) · The American Journal of Human Genetics · doi:10.1086/374822 · Cited by 263 · see citing works
Kazuno, A., Munakata, K., Nagai, T., Shimozono, S., Tanaka, M., Yoneda, M., Kato, N., Miyawaki, A., & Kato, T. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020128 · Cited by 234 · see citing works
Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine
Ben-Shachar, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01263.x · Cited by 232 · see citing works
Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90097-4 · Cited by 227 · see citing works
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227 · see citing works
Novel Insights into Lithium’s Mechanism of Action: Neurotrophic and Neuroprotective Effects
Quiroz, J. A., Machado‐Vieira, R., Zarate, C. A., & Manji, H. K. (2010) · Neuropsychobiology · doi:10.1159/000314310 · Cited by 225 · see citing works
Kato, T., Takahashi, S., Shioiri, T., Murashita, J., Hamakawa, H., & Inubushi, T. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90116-3 · Cited by 223 · see citing works
Maurer, I., Zierz, S., & Möller, H. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00075-x · Cited by 221 · see citing works
Patterns of maternal transmission in bipolar affective disorder.
McMahon, F. J., Stine, O. C., Meyers, D. A., Simpson, S. G., & DePaulo, J. R. (1995) · Europe PMC (PubMed Central) · Cited by 217 · see citing works
Ben‐Shachar, D., & Karry, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003676 · Cited by 215 · see citing works
Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
Rollins, B. L., Martin, M. V., Sequeira, A., Moon, E. A., Morgan, L. Z., Watson, S. J., Schatzberg, A. F., Akil, H., Myers, R., Jones, E. G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004913 · Cited by 212 · see citing works
The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities
Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 210 · see citing works
Review of the Literature on Major Mental Disorders in Adult Patients With Mitochondrial Diseases
Fattal, O., Budur, K., Vaughan, A. J., & Franco, K. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.1.1 · Cited by 209 · see citing works
Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study
Karry, R., Klein, E., & Ben‐Shachar, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.012 · Cited by 208 · see citing works
Kyle, U. G., & Pichard, C. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232898.74415.42 · Cited by 208 · see citing works
Neurophysiological Endophenotypes Across Bipolar and Schizophrenia Psychosis
Thaker, G. K. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn049 · Cited by 204 · see citing works
Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation.
Reis, R. J. S., & Goldstein, S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44633-3 · Cited by 203 · see citing works
Evidence for shared susceptibility in bipolar disorder and schizophrenia
Berrettini, W. H. (2003) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.20014 · Cited by 197 · see citing works
A Review of Disrupted-in-Schizophrenia-1 (disc1): Neurodevelopment, Cognition, and Mental Conditions
Ishizuka, K., Paek, M., Kamiya, A., & Sawa, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.065 · Cited by 190 · see citing works
Creatine abnormalities in schizophrenia and bipolar disorder
Öngür, D., Prescot, A. P., Jensen, J. E., Cohen, B. M., & Renshaw, P. F. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.06.002 · Cited by 190 · see citing works
Induction of Reactive Oxygen Species in Neurons by Haloperidol
Sagara, Y. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71031002.x · Cited by 189 · see citing works
Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress
Brown, J. M., & Yamamoto, B. K. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00052-4 · Cited by 185 · see citing works
Vawter, M. P., Tomita, H., Meng, F., Bolstad, B. M., Li, J., Evans, S. J., Choudary, P. V., Atz, M. E., Shao, L., Neal, C. R., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001830 · Cited by 181 · see citing works
King, T. D., Bijur, G. N., & Jope, R. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03005-0 · Cited by 176 · see citing works
Kasahara, T., Kubota, M., Miyauchi, T., Noda, Y., Mouri, A., Nabeshima, T., & Kato, T. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001824 · Cited by 176 · see citing works
Regenold, W. T., Phatak, P., Marano, C. M., Sassan, A., Conley, R. R., & Kling, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.010 · Cited by 171 · see citing works
Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder
Quiroz, J. A., Gray, N. A., Kato, T., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301671 · Cited by 170 · see citing works
Bachmann, R. F., Wang, Y., Yuan, P., Zhou, R., Li, X., Alesci, S., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009802 · Cited by 165 · see citing works
Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia
Berrettini, W. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00226-7 · Cited by 161 · see citing works
Cavelier, L. B., JAZIN, E. E., Eriksson, I., Prince, J. A., Båve, U., Oreland, L., & Gyllensten, U. B. (1995) · Genomics · doi:10.1006/geno.1995.1234 · Cited by 157 · see citing works
Schizophrenia and bipolar disorder: differences and overlaps
Maier, W., Zobel, A., & Wagner, M. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214342.52249.82 · Cited by 156 · see citing works
Abnormal frontal lobe phosphorous metabolism in bipolar disorder
Deicken, R. F., Fein, G., & Weiner, M. W. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.915 · Cited by 154 · see citing works
James, R., Adams, R. R., CHRISTIE, S., Buchanan, S. R., Porteous, D. J., & Millar, J. K. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.013 · Cited by 150 · see citing works
Williams, N. M., Green, E., MacGregor, S., Dwyer, S., Norton, N., Williams, H. J., Raybould, R., Grozeva, D., Hamshere, M. L., Zammit, S., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.366 · Cited by 148 · see citing works
Dror, N., Klein, E., Karry, R., Sheinkman, A., Kirsh, Z., Mazor, M., Tzukerman, M., & Ben‐Shachar, D. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001116 · Cited by 146 · see citing works
Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia
Karlsgodt, K. H., Sun, D., Jimenez, A. M., Lutkenhoff, E. S., Willhite, R., van Erp, T. G. M., & Cannon, T. D. (2008) · Development and Psychopathology · doi:10.1017/s095457940800062x · Cited by 145 · see citing works
Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes
Maynard, T. M., Meechan, D. W., Dudevoir, M. L., Gopalakrishna, D., Peters, A. Z., Heindel, C., Sugimoto, T. J., Wu, Y., Lieberman, J. A., & LaMantia, A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.027 · Cited by 142 · see citing works
Populations of hippocampal inhibitory neurons express different levels of cytochrome <i>c</i>
Gulyás, A. I., Buzsáki, G., Freund, T. F., & Hirase, H. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04814.x · Cited by 142 · see citing works
Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients
Dubovsky, S. L., Murphy, J. R., Thomas, M. R., & Rademacher, J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.118 · Cited by 140 · see citing works
Lithium‐induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue
Maurer, I., Schippel, P., & Volz, H. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00729.x · Cited by 136 · see citing works
Einat, H., YUAN, P., & Manji, H. K. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.06.012 · Cited by 131 · see citing works
Munakata, K., Iwamoto, K., Bundo, M., & Kato, T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.041 · Cited by 127 · see citing works
Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder
Kato, T., Stine, O. C., McMahon, F. J., & Crowe, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00012-7 · Cited by 124 · see citing works
Valvassori, S. S., Rezin, G. T., Ferreira, C. L., Moretti, M., Gonçalves, C. L., Cardoso, M. R., STRECK, E. L., Kapczinski, F. P., & Quevedo, J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.009 · Cited by 119 · see citing works
Kvajo, M., Albers, A. D., Swor, D. E., Karayiorgou, M., & Gogos, J. A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002052 · Cited by 116 · see citing works
Kato, T., Shioiri, T., Murashita, J., Hamakawa, H., Takahashi, Y., Inubushi, T., & Takahashi, S. (1995) · Psychological Medicine · doi:10.1017/s003329170003347x · Cited by 115 · see citing works
Increased mitochondrial complex I activity in platelets of schizophrenic patients
Ben‐Shachar, D., Zuk, R., Gazawi, H., Reshef, A., Sheinkman, A., & Klein, E. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001649 · Cited by 113 · see citing works
Mitochondrial DNA 3644T→C mutation associated with bipolar disorder
Munakata, K., Tanaka, M., Mori, K., Washizuka, S., Yoneda, M., Tajima, O., Akiyama, T., Nanko, S., Kunugi, H., Tadokoro, K., et al. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.015 · Cited by 113 · see citing works
Frey, B. N., Stanley, J. A., Nery, F. G., Monkul, E. S., Nicoletti, M., Chen, H., Hatch, J. P., Caetano, S. C., Ortíz, O., Kapczinski, F. P., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00454.x · Cited by 113 · see citing works
Decreased brain intracellular pH measured by
Kato, T., Murashita, J., Kamiya, A., Shioiri, T., Kato, N., & Inubushi, T. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050054 · Cited by 113 · see citing works
Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer, J. W. (2004) · PubMed · Cited by 109 · see citing works
Sharma, R. P., Rosen, C., Kartan, S., Guidotti, A., Costa, E., Grayson, D. R., & Chase, K. A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.015 · Cited by 107 · see citing works
Maurer, I., & Möller, H. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6111-8_40 · Cited by 106 · see citing works
Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging
Fujimoto, T., Nakano, T., Takano, T., Hokazono, Y., Asakura, T., & Tsuji, T. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03297.x · Cited by 105 · see citing works
Lack of age-related increase of mitochondrial DNA amount in brain, skeletal muscle and human heart
Frahm, T., Mohamed, S. A., Bruse, P., Gemünd, C., Oehmichen, M., & Meißner, C. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.06.008 · Cited by 100 · see citing works
Naydenov, A. V., MacDonald, M. L., Öngür, D., & Konradi, C. L. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.555 · Cited by 99 · see citing works
Self-citationHerberth, M., Koethe, D., Cheng, T. M. K., Krzyszton, N. D., Schoeffmann, S., Guest, P. C., Rahmoune, H., Harris, L. W., Kranaster, L., Leweke, F. M., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.71 · Cited by 98 · see citing works
Disrupted In Schizophrenia 1 (DISC1): Subcellular targeting and induction of ring mitochondria
Millar, J. K., James, R., Christie, S., & Porteous, D. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.08.021 · Cited by 96 · see citing works
Maurer, I., & Möller, H. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006872911332 · Cited by 96 · see citing works
Mitochondrial metabolism of valproic acid
Jianxun, L., Norwood, D. L., Mao, L. F., & Schulz, H. (1991) · Biochemistry · doi:10.1021/bi00216a012 · Cited by 95 · see citing works
Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study
Stanley, J. A., Williamson, P., Drost, D. J., Carr, T., Rylett, R. J., Morrison-Stewart, S. L., & Thompson, R. T. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90044-2 · Cited by 95 · see citing works
A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress
Marchbanks, R. M., Ryan, M., Day, I. N. M., Owen, M., McGuffin, P., & Whatley, S. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00011-2 · Cited by 93 · see citing works
Gavin, D. P., Kartan, S., Chase, K. A., Jayaraman, S., & Sharma, R. P. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.006 · Cited by 92 · see citing works
MacDonald, M. L., Naydenov, A. V., Chu, M. S., Matzilevich, D., & Konradi, C. L. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00302.x · Cited by 92 · see citing works
Self-citationMichaelis, M., Suhan, T. O., Michaelis, U. R., Beek, K. V., Rothweiler, F., Tausch, L., Werz, O., Eikel, D., Zörnig, M., Nau, H., et al. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401759 · Cited by 91 · see citing works
Chen, W.-Y., Shi, Y., Zheng, Y., Zhao, X., Zhang, G., Chen, S.-Q., Yang, P.-D., & He, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh322 · Cited by 90 · see citing works
Schizophrenia and smoking: Evidence for a common neurobiological basis?
Stassen, H. H., Bridler, R., H�gele, S., Hergersberg, M., Mehmann, B., Schinzel, A., Weisbrod, M., & Scharfetter, C. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000403)96:2 · Cited by 89 · see citing works
Chronic Lithium Treatment Attenuates Intracellular Calcium Mobilization
Wasserman, M. J., Corson, T. W., Sibony, D., Cooke, R. G., Parikh, S. V., Pennefather, P., Li, P. P., & Warsh, J. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300400 · Cited by 88 · see citing works
Differential effects of typical and atypical neuroleptics on mitochondrial functionin vitro
Modica-Napolitano, J. S., Lagace, C. J., Brennan, W. A., & Aprille, J. R. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02980205 · Cited by 86 · see citing works
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder
Washizuka, S., Kakiuchi, C., Mori, K., Kunugi, H., Tajima, O., Akiyama, T., Nanko, S., & Kato, T. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20041 · Cited by 86 · see citing works
Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls
Yurgelun-Todd, D. A., Renshaw, P. F., Gruber, S. A., WATERNAUX, C. M., & Cohen, B. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00071-2 · Cited by 83 · see citing works
Neuroleptic-Induced Mitochondrial Enzyme Alterations in the Rat Brain
Prince, J. A., Yassin, M. S., & Oreland, L. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36399-2 · Cited by 83 · see citing works
Li, T., Ma, X., Sham, P. C., Sun, X., Hu, X., Wang, Q., Meng, H., Deng, W., Liu, X., Murray, R. M., et al. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30049 · Cited by 82 · see citing works
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia
Boks, M. P., Rietkerk, T., van de Beek, M. H., Sommer, I. E., de Koning, T. J., & Kahn, R. S. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.12.003 · Cited by 80 · see citing works
Dopamine Inhibits Mitochondrial Motility in Hippocampal Neurons
Chen, S., Owens, G. C., & Edelman, D. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002804 · Cited by 79 · see citing works
Ouyang, Y., & Giffard, R. G. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.02.015 · Cited by 78 · see citing works
Pysh, J. J., & Khan, T. A. (1972) · Brain Research · doi:10.1016/0006-8993(72)90762-7 · Cited by 78 · see citing works
Glutathione S‐transferase is a novel target for mood stabilizing drugs in primary cultured neurons
Wang, J., Shao, L., Sun, X., & Young, L. T. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02276.x · Cited by 76 · see citing works
[Mitochondrial dysfunction in bipolar disorder].
Kato, T. (2005) · PubMed · Cited by 76 · see citing works
Behavioral changes in G72/G30 transgenic mice
Otte, D. M., Bilkei‐Gorzó, A., Filiou, M. D., Turck, C. W., Yilmaz, Ö., Holst, M. I., Schilling, K., Jamra, R. A., Schumacher, J., Benzel, I. M., et al. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.12.009 · Cited by 72 · see citing works
Kato, T., Ishiwata, M., Mori, K., Washizuka, S., Tajima, O., Akiyama, T., & Kato, N. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003717 · Cited by 72 · see citing works
Kakiuchi, C., Ishiwata, M., Kametani, M., Nelson, C., Iwamoto, K., & Kato, T. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005213 · Cited by 72 · see citing works
Washizuka, S., Iwamoto, K., Kakiuchi, C., Bundo, M., & Kato, T. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.12.004 · Cited by 70 · see citing works
Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia
Arinami, T. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0058-5 · Cited by 69 · see citing works
Shalbuyeva, N., Brustovetsky, T., & Brustovetsky, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702134200 · Cited by 68 · see citing works
Mitochondrial DNA sequence diversity in bipolar affective disorder.
McMahon, F., Chen, Y.-S., Patel, S., Kokoszka, J., Brown, M. D., Torroni, A., DePaulo, J., & Wallace, D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1058 · Cited by 64 · see citing works
Washizuka, S., Ikeda, A., Kato, N., & Kato, T. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003778 · Cited by 63 · see citing works
Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia
Ueno, H., Nishigaki, Y., Kong, Q., Fuku, N., Kojima, S., Iwata, N., Ozaki, N., & Tanaka, M. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.06.003 · Cited by 63 · see citing works
Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders
Kusumi, I., Koyama, T., & Yamashita, I. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90305-j · Cited by 62 · see citing works
Struewing, I. T., Barnett, C. D., Tang, T., & Mao, C. D. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05809.x · Cited by 61 · see citing works
Hercher, L., & Bruenner, G. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32466 · Cited by 61 · see citing works
Subcellular targeting of DISC1 is dependent on a domain independent from the Nudel binding site
Brandon, N. J., Schurov, I., Camargo, L. M., Handford, E. J., Duran-Jimenez, B., Hunt, P., Millar, J. K., Porteous, D. J., Shearman, M. S., & Whiting, P. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.11.003 · Cited by 60 · see citing works
Jensen, J. E., Miller, J., Williamson, P., Neufeld, R. W. J., Menon, R. S., MALLA, A. K., Manchanda, R., Schaefer, B., Densmore, M., & Drost, D. J. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.11.004 · Cited by 59 · see citing works
Deicken, R. F. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00036-8 · Cited by 59 · see citing works
Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder
Prata, D. P., Breen, G. D., Osborne, S., Munro, J., Clair, D. S., & Collier, D. A. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30682 · Cited by 58 · see citing works
Washizuka, S., Kametani, M., Sasaki, T., Tochigi, M., Umekage, T., Kohda, K., & Kato, T. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30285 · Cited by 57 · see citing works
Prayson, R. A., & Wang, N. (1998) · PubMed · Cited by 54 · see citing works
Cerebral phosphate metabolism in first‐degree relatives of patients with schizophrenia
Klemm, S., Rzanny, R., Riehemann, S., Volz, H.-P., Schmidt, B., Gerhard, U.-J., Filz, C., Schönberg, A., Mentzel, H.-J., Kaiser, W. A., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.958 · Cited by 52 · see citing works
Kirk, R., Furlong, R. A., Amos, W., Cooper, G., Rubinsztein, J. S., Walsh, C., Paykel, E. S., & Rubinsztein, D. C. (1999) · The American Journal of Human Genetics · doi:10.1086/302507 · Cited by 51 · see citing works
Brenner-Lavie, H., Klein, E., & Ben‐Shachar, D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.024 · Cited by 51 · see citing works
Ousley, O., Rockers, K., Dell, M. L., Coleman, K. B., & Cubells, J. F. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0085-8 · Cited by 48 · see citing works
Bass, N. J., Datta, S. R., McQuillin, A., Puri, V., Choudhury, K., Thirumalai, S., Lawrence, J., Quested, D. J., Pimm, J., Curtis, D., et al. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-28 · Cited by 48 · see citing works
Deicken, R. F., Calabrese, G., Merrin, E. L., Vinogradov, S., Fein, G., & Weiner, M. W. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00372-a · Cited by 47 · see citing works
Expression of mitochondria‐related genes in lymphoblastoid cells from patients with bipolar disorder
Washizuka, S., Kakiuchi, C., Mori, K., Tajima, O., Akiyama, T., & Kato, T. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00184.x · Cited by 47 · see citing works
Mitochondrial related gene expression changes are sensitive to agonal-pH state
Vawter, M. P., Tomita, H., Meng, F., Bolstad, B. M., Li, J., Evans, S. J., Choudary, P. V., Atz, M. E., Shao, L., Neal, C. R., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001850 · Cited by 46 · see citing works
Protective effect of trifluoperazine on the mitochondrial damage induced by Ca2+ plus prooxidants
Pereira, R. D. S., Bertocchi, A. P. F., & Vercesi, A. E. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90074-s · Cited by 42 · see citing works
Jou, M., Peng, T., WU, H., & Wei, Y. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.024 · Cited by 40 · see citing works
Xu, C. D., Li, P. P., Kennedy, J. L., Green, M., Hughes, B., Cooke, R. G., Parikh, S. V., & Warsh, J. J. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00535.x · Cited by 40 · see citing works
Fuke, S., Kametani, M., & Kato, T. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.009 · Cited by 39 · see citing works
Region-specific changes in mitochondrial D-loop in aged rat CNS
McInerny, S., Brown, A. L., & Smith, D. W. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.01.008 · Cited by 39 · see citing works
Comparative pharmacology of bipolar disorder and schizophrenia
Post, R. M. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00115-2 · Cited by 39 · see citing works
Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs
Amar, S., Shamir, A., Ovadia, O., Blanaru, M., Reshef, A., Kremer, I., Rietschel, M., Schulze, T. G., Maier, W., Belmaker, R. H., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.020 · Cited by 39 · see citing works
The ultrastructure of lymphocytes in schizophrenia
Uranova, N. A., Бонарцев, П. Д., Os, B., Ma, M., Rachmanova, V. I., & Orlovskaya, D. D. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600960207 · Cited by 38 · see citing works
No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia
DeLisi, L. E., Razi, K., Stewart, J., Relja, M., Shields, G. W., Smith, A., Wellman, N. A., Larach, V. W., Loftus, J., Vita, A., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00939-2 · Cited by 35 · see citing works
Inuwa, I., Peet, M., & Williams, M. (2005) · Biotechnic & Histochemistry · doi:10.1080/10520290500303349 · Cited by 34 · see citing works
Mitochondrial free radical production induced by glucose deprivation in cerebellar granule neurons
Исаев, Н. К., Stelmashook, E. V., Dirnagl, U., Plotnikov, E. Y., Kuvshinova, E. A., & Zorov, D. B. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908020053 · Cited by 34 · see citing works
Approaches for Unraveling the Joint Genetic Determinants of Schizophrenia and Bipolar Disorder
Lin, P., & Mitchell, B. D. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn050 · Cited by 34 · see citing works
WANG, J., & LÜ, Y.-Y. (2009) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2009.04.0014 · Cited by 33 · see citing works
Prince, J. A., Yassin, M. S., & Oreland, L. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00152-4 · Cited by 33 · see citing works
Liu, C.-Y., Lee, C.-F., & Wei, Y.-H. (2007) · Mitochondrion · doi:10.1016/j.mito.2006.11.020 · Cited by 33 · see citing works
Phospholipids and calcium alterations in platelets of schizophrenic patients.
Rípová, D., Strunecká, A., Němcová‐Fürstová, V., & Farská, I. (1997) · PubMed · Cited by 31 · see citing works
Mancuso, M., Ricci, G., Choub, A., Filosto, M., DiMauro, S., Davidzon, G., Tessa, A., Santorelli, F. M., Murri, L., & Siciliano, G. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.05.016 · Cited by 29 · see citing works
Mitochondrial DNA haplogroup analysis in patients with bipolar disorder
Kazuno, A., Munakata, K., Mori, K., Nanko, S., Kunugi, H., Nakamura, K., Mori, N., Yamada, K., Yoshikawa, T., Kato, N., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30804 · Cited by 29 · see citing works
Kazuno, A., Munakata, K., Kato, N., & Kato, T. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007614 · Cited by 27 · see citing works
Stoffel, M., Karayiorgou, M., Espinosa, R., & Beau, M. M. L. (1996) · Human Genetics · doi:10.1007/s004390050169 · Cited by 26 · see citing works
Baron, K. T., Wang, G. J., Padua, R. A., Campbell, C., & Thayer, S. A. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.022 · Cited by 24 · see citing works
Mania as a first presentation in mitochondrial myopathy
GROVER, S., Padhy, S. K., Das, C. P., Vasishta, R. K., Sharan, P., & Chakrabarti, S. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01599.x · Cited by 22 · see citing works
Stelmashook, E. V., Исаев, Н. К., Plotnikov, E. Y., Uzbekov, R. E., Alieva, I. B., Arbeille, B., & Zorov, D. B. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.073 · Cited by 22 · see citing works
Campos, Y., García‐Redondo, A., Eiris, J., Fuster, M., Rubio‐Terres, C., Martín, M. A., del Hoyo, P., Pintos, E., Gago, M. C., & Arenas, J. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012719211505 · Cited by 21 · see citing works
Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients
Klushnik, T. P., Spunde, A. Y., Yakovlev, A. G., Khuchua, Z. A., Saks, V. A., & Vartanian, M. E. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03161065 · Cited by 20 · see citing works
New directions in the conceptualization of psychotic disorders
Kroll, J. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f08759 · Cited by 19 · see citing works
Plant, N. J., Barber, P. C., Horner, E., Cockburn, C.-L., Gibson, G. G., Bugelski, P. J., & Lord, P. G. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9463 · Cited by 16 · see citing works
Kasahara, T., Kubota, M., Miyauchi, T., Ishiwata, M., & Kato, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001877 · Cited by 16 · see citing works
Karlsgodt, K. H., Sun, D., Jimenez, A. M., Lutkenhoff, E. S., Willhite, R., van Erp, T. G. M., & Cannon, T. D. (2008) · Cited by 16 · see citing works
Ben‐Shachar, D., Nadri, C., Karry, R., & Agam, G. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9144-9 · Cited by 15 · see citing works
Zhang, J., Li, X., Wang, Y., Ji, J., Yang, F., Feng, G., Wan, P., Lindpaintner, K., He, L., & He, G. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0185-1 · Cited by 15 · see citing works
Parent-of-origin effect in the segregation analysis of bipolar affective disorder families
Lan, T., Beaty, T. H., DePaulo, J. R., & McInnis, M. G. (2007) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328013e604 · Cited by 13 · see citing works
DNA Polymorphisms and Bipolar Disorder
Kato, T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1169-b · Cited by 7 · see citing works
Volkow (1999) · doi:10.1002/(sici)1098-2396(199901)31:1
Flagged first, then by citations
1 of the 189 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The role of methionine on metabolism, oxidative stress, and diseases
Martínez, Y., Li, X., Liu, G., Bin, P., Yan, W., Más, D., Valdivié, M., Hu, C.-A. A., Ren, W., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2494-2 · Cited by 583 · see citing works
Dendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581 · see citing works
Rossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 545 · see citing works
How might circadian rhythms control mood? Let me count the ways
McClung, C. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.019 · Cited by 507 · see citing works
Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling
Wu, Y., Chen, M., & Jiang, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.003 · Cited by 378 · see citing works
An updated meta-analysis of oxidative stress markers in bipolar disorder
Brown, N. C., Andreazza, A. C., & Young, L. T. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.005 · Cited by 333 · see citing works
Mansur, R. B., Brietzke, E. M., & McIntyre, R. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.017 · Cited by 325 · see citing works
Mitochondrial iron–sulfur protein biogenesis and human disease
Stehling, O., Wilbrecht, C., & Lill, R. (2014) · Biochimie · doi:10.1016/j.biochi.2014.01.010 · Cited by 272 · see citing works
Vitamin D deficiency and diabetes
Berridge, M. J. (2017) · Biochemical Journal · doi:10.1042/bcj20170042 · Cited by 265 · see citing works
Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works
OXPHOS mutations and neurodegeneration
Koopman, W. J. H., Distelmaier, F., Smeitink, J. A. M., & Willems, P. H. G. M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.300 · Cited by 254 · see citing works
Neurodevelopment, GABA System Dysfunction, and Schizophrenia
Schmidt, M. J., & Mirnics, K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.95 · Cited by 239 · see citing works
Karabatsiakis, A., Böck, C., Salinas-Manrique, J., Kolassa, S., Calzia, E., Dietrich, D. E., & Kolassa, I. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.44 · Cited by 239 · see citing works
Biological hypotheses and biomarkers of bipolar disorder
Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12476 · Cited by 247 · see citing works
Behavior genetics and postgenomics
Charney, E. (2012) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11002226 · Cited by 207 · see citing works
Antioxidants as Antidepressants
Scapagnini, G., Davinelli, S., Drago, F., LORENZO, A. D., & Oriani, G. (2012) · CNS Drugs · doi:10.2165/11633190-000000000-00000 · Cited by 184 · see citing works
Vitamin D and Depression: Cellular and Regulatory Mechanisms
Berridge, M. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013227 · Cited by 186 · see citing works
Scaini, G., Rezin, G. T., Carvalho, A. F., STRECK, E. L., Berk, M., & Quevedo, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.040 · Cited by 184 · see citing works
Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia
Bergman, O., & Ben‐Shachar, D. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716648290 · Cited by 175 · see citing works
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium
de Sousa, R. T., Zarate, C. A., Zanetti, M. V., Costa, A. C., Talib, L. L., Gattaz, W. F., & Machado-Vieira, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.11.011 · Cited by 169 · see citing works
Paulsen, B. D. S., Maciel, R. D. M., Galina, A., Silveira, M. S., Souza, C. D. S., Drummond, H., Pozzatto, E. N., Silva, H., Chicaybam, L., Massuda, R., et al. (2011) · Cell Transplantation · doi:10.3727/096368911x600957 · Cited by 162 · see citing works
A model of the mitochondrial basis of bipolar disorder
Morris, G., Walder, K., McGee, S. L., Dean, O. M., Tye, S. J., Maes, M., & Berk, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.014 · Cited by 162 · see citing works
Sethi, S., Wakeham, D. E., Ketter, T. A., Hooshmand, F., Bjornstad, J., Richards, B. J., Westman, E. C., Krauss, R. M., & Saslow, L. R. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115866 · Cited by 158 · see citing works
Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157 · see citing works
The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients
Danan, A., Westman, E. C., Saslow, L. R., & Ede, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.951376 · Cited by 151 · see citing works
Andreazza, A. C., Wang, J., Salmasi, F., Shao, L., & Young, L. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12316 · Cited by 146 · see citing works
Davis, J., Moylan, S., Harvey, B. H., Maes, M. H. J., & Berk, M. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414533012 · Cited by 147 · see citing works
Konradi, C. L., Daws, S. E., & Clay, H. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.025 · Cited by 148 · see citing works
Self-citationThe role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140 · see citing works
Physical Exercise for Treatment of Mood Disorders: A Critical Review
Hearing, C. M., Chang, W. C., Szuhany, K. L., Deckersbach, T., Nierenberg, A. A., & Sylvia, L. G. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0089-y · Cited by 137 · see citing works
McCarthy, M. J., Gottlieb, J. F., Gonzalez, R., McClung, C. A., Alloy, L. B., Cain, S., Dulcis, D., Etain, B., Frey, B. N., Garbazza, C., et al. (2022) · Bipolar Disorders · doi:10.1111/bdi.13165 · Cited by 136 · see citing works
Du, F., Cooper, A. J., Thida, T., Sehovic, S., Lukas, S. E., Cohen, B. M., Zhang, X., & Öngür, D. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2287 · Cited by 134 · see citing works
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132 · see citing works
Kim, H. K., Andreazza, A. C., Elmi, N., Chen, W., & Young, L. T. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.015 · Cited by 128 · see citing works
Dogan, A. E., Yüksel, Ç., Du, F., Chouinard, V., & Öngür, D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0041-9 · Cited by 128 · see citing works
Liu, W.-N., & Zhou, C.-L. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.12.003 · Cited by 126 · see citing works
Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124 · see citing works
Adult Neurogenesis Transiently Generates Oxidative Stress
Walton, N. M., Shin, R. S., Tajinda, K., Heusner, C. L., Kogan, J. H., Miyake, S., Chen, Q., Tamura, K., & Matsumoto, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035264 · Cited by 119 · see citing works
Hashimoto‐Torii, K., Torii, M., Fujimoto, M., Nakai, A., Fatimy, R. E., Mezger, V., Ju, M. J., Ishii, S., Chao, S.-H., Brennand, K., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.002 · Cited by 118 · see citing works
Cattane, N., Richetto, J., & Cattaneo, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 118 · see citing works
Napoli, E., Ross‐Inta, C., Wong, S., Hung, C., Fujisawa, Y., Sakaguchi, D., Angelastro, J. M., Omanska-Klusek, A., Schoenfeld, R. A., & Giulivi, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042504 · Cited by 116 · see citing works
Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies
Roberts, R. C. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.009 · Cited by 110 · see citing works
Balancing histone methylation activities in psychiatric disorders
Peter, C. J., & Akbarian, S. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.003 · Cited by 110 · see citing works
DISC1 genetics, biology and psychiatric illness
Thomson, P. A., Malavasi, E. L. V., Grünewald, E., Soares, D. C., Borkowska, M., & Millar, J. K. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1254-7 · Cited by 109 · see citing works
Goetzl, E. J., Wolkowitz, O. M., Srihari, V. H., Reus, V. I., Goetzl, L. M., Kapogiannis, D., Heninger, G. R., & Mellon, S. H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01268-x · Cited by 109 · see citing works
Neurodevelopmental origins of bipolar disorder: iPSC models
O’Shea, K. S., & McInnis, M. G. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.006 · Cited by 107 · see citing works
Putative neuroprotective agents in neuropsychiatric disorders
Dodd, S., Maes, M. H. J., Anderson, G., Dean, O. M., Moylan, S., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.007 · Cited by 105 · see citing works
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works
“It has been shown that, in BD, the occurrence of mitochondrial DNA mutations and the occurrence of other mitochondrial diseases are rather high [32].”
BackgroundEvidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia
Hjelm, B. E., Rollins, B. L., Mamdani, F., Lauterborn, J. C., Kirov, G., LYNCH, G. S., Gall, C. M., Sequeira, A., & Vawter, M. P. (2015) · Complex Psychiatry · doi:10.1159/000441252 · Cited by 94 · see citing works
Postmortem studies on mitochondria in schizophrenia
Roberts, R. C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.056 · Cited by 97 · see citing works
Feng, Z., Zou, X., Jia, H., Li, X., Zhu, Z., Liu, X., Bucheli, P., Ballèvre, O. P., Hou, Y., Zhang, W., et al. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3750 · Cited by 97 · see citing works
Schubert, K. O., Föcking, M., & Cotter, D. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.002 · Cited by 95 · see citing works
Du, F., Yüksel, Ç., Chouinard, V., Huynh, P., Ryan, K. P., Cohen, B. M., & Öngür, D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.025 · Cited by 96 · see citing works
Regenold, W. T., Pratt, M., Nekkalapu, S., Shapiro, P. S., Kristián, T., & Fiskum, G. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.018 · Cited by 96 · see citing works
Reduced antioxidant defense systems in schizophrenia and bipolar I disorder
Raffa, M., Barhoumi, S., Atig, F., Fendri, C., Kerkeni, A., & Mechri, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.013 · Cited by 95 · see citing works
Rose, S., Melnyk, S., Trusty, T. A., Pavliv, O., Seidel, L., Li, J., Nick, T. G., & James, S. J. (2011) · Autism Research and Treatment · doi:10.1155/2012/986519 · Cited by 93 · see citing works
Schizophrenia as a Disorder of Molecular Pathways
Horváth, S., & Mirnics, K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.001 · Cited by 90 · see citing works
Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging
Gu, X., Ke, S., Wang, Q., Zhuang, T., Xia, C., Xu, Y., Yang, L., & Zhou, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111869 · Cited by 89 · see citing works
Rege, S., & Hodgkinson, S. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413499077 · Cited by 90 · see citing works
Zhang, Y., Sun, Y., Wang, F., Wang, Z., Peng, Y., & Li, R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0724-2 · Cited by 89 · see citing works
Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness
Kohen, R., Dobra, A., Tracy, J. H., & Haugen, E. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.9 · Cited by 87 · see citing works
Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia
Kraguljac, N. V., Reid, M. A., White, D. M., den Hollander, J., & Lahti, A. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.126 · Cited by 84 · see citing works
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
Markkanen, E., Meyer, U., & Dianov, G. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060856 · Cited by 84 · see citing works
The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies
Palmer, C. M., Gilbert‐Jaramillo, J., & Westman, E. C. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.019 · Cited by 82 · see citing works
Pruett, B. S., & Meador‐Woodruff, J. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.003 · Cited by 80 · see citing works
Andreazza, A. C., & Young, L. T. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000096 · Cited by 80 · see citing works
Decreased global methylation in patients with bipolar disorder who respond to lithium
Huzayyin, A. A. S., Andreazza, A. C., Turecki, G., Cruceanu, C., Rouleau, G. A., Alda, M., & Young, L. T. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001569 · Cited by 80 · see citing works
Crispino, M., Trinchese, G., Penna, E., Cimmino, F., Catapano, A., Villano, I., Perrone‐Capano, C., & Mollica, M. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175964 · Cited by 79 · see citing works
Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Scaini, G., Andrews, T., Lima, C. N. D. C., Benevenuto, D., STRECK, E. L., & Quevedo, J. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.002 · Cited by 77 · see citing works
Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 76 · see citing works
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal
Romano, A., Serviddio, G., Calcagnini, S., Villani, R., Giudetti, A. M., Cassano, T., & Gaetani, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.046 · Cited by 77 · see citing works
Lee, S., Tsao, T. T.-H., Yang, K.-C., Lin, H., Kuo, Y.-L., Hsu, C.-H., Lee, W., Huang, K.-C., & Kao, C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s13-s20 · Cited by 72 · see citing works
The 7q11.23 Protein DNAJC30 Interacts with ATP Synthase and Links Mitochondria to Brain Development
Tebbenkamp, A. T. N., Varela, L., Choi, J., Paredes, M. I., Giani, A. M., Song, J. E., Šestan-Peša, M., Franjic, D., Sousa, A. M. M., Liu, Z.-W., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.014 · Cited by 71 · see citing works
Chang, C., Jou, S., Lin, T., & Liu, C. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12163 · Cited by 72 · see citing works
Kasote, D. M., Hegde, M. V., & Katyare, S. S. (2013) · BioFactors · doi:10.1002/biof.1093 · Cited by 71 · see citing works
Complex I deficiencies in neurological disorders
Papa, S., & Rasmo, D. D. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.005 · Cited by 72 · see citing works
Parvalbumin interneuron deficits in schizophrenia
Marín, Ó. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.02.010 · Cited by 72 · see citing works
Kim, H. K., Chen, W., & Andreazza, A. C. (2015) · Neural Plasticity · doi:10.1155/2015/408136 · Cited by 71 · see citing works
Munkholm, K., Peijs, L., Vinberg, M., & Kessing, L. V. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.110 · Cited by 71 · see citing works
Machado‐Vieira, R., Soeiro‐de‐Souza, M. G., Richards, E. M., Teixeira, A. L., & Zarate, C. A. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.830775 · Cited by 70 · see citing works
Ketogenic diet in the treatment of schizoaffective disorder: Two case studies
Palmer, C. M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.053 · Cited by 70 · see citing works
SOUSA, R. T. D., STRECK, E. L., Zanetti, M. V., Ferreira, G. K., Diniz, B. S., Brunoni, A. R., Busatto, G. F., Gattaz, W. F., & Machado‐Vieira, R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3655-6 · Cited by 70 · see citing works
Psychiatric symptoms of patients with primary mitochondrial DNA disorders
Inczédy-Farkas, G., Reményi, V., Gál, A., Varga, Z., Balla, P., Udvardy-Mészáros, Á., Bereznai, B., & Molnár, M. J. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-9 · Cited by 70 · see citing works
Park, S. J., Lee, S. B., Suh, Y., Kim, S.-J., Lee, N., Hong, J., Park, C., Woo, Y., Ishizuka, K., Kim, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.043 · Cited by 70 · see citing works
Duarte, J. M. N., & Xin, L. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2521-z · Cited by 69 · see citing works
The Complex Interaction of Mitochondrial Genetics and Mitochondrial Pathways in Psychiatric Disease
Cuperfain, A. B., Zhang, Z. L., Kennedy, J. L., & Gonçalves, V. F. (2018) · Complex Psychiatry · doi:10.1159/000488031 · Cited by 68 · see citing works
Gandal, M. J., Nesbitt, A. M., McCurdy, R. M., & Alter, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041215 · Cited by 67 · see citing works
Frye, R. E., Cakir, J., Rose, S., Delhey, L. M., Bennuri, S. C., Tippett, M., Melnyk, S., James, S. J., Palmer, R. F., Austin, C. E., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00885-2 · Cited by 67 · see citing works
Madireddy, S., & Madireddy, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031844 · Cited by 71 · see citing works
Hutcheson, N. L., Reid, M. A., White, D. M., Kraguljac, N. V., Avsar, K. B., Bolding, M., Knowlton, R. C., den Hollander, J. A., & Lahti, A. C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.039 · Cited by 65 · see citing works
Connectivity between mitochondrial functions and psychiatric disorders
Hroudová, J., & Fišar, Z. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02178.x · Cited by 62 · see citing works
Głombik, K., Stachowicz, A., Ślusarczyk, J., Trojan, E., Budziszewska, B., Suski, M., Kubera, M., Lasoń, W., Wędzony, K., Olszanecki, R., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.015 · Cited by 64 · see citing works
Mood‐related central and peripheral clocks
Ketchesin, K. D., Becker‐Krail, D. D., & McClung, C. A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14253 · Cited by 60 · see citing works
Differential mitochondrial DNA copy number in three mood states of bipolar disorder
Wang, D., Li, Z., Liu, W., Zhou, J., Ma, X., Tang, J., & Chen, X. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1717-8 · Cited by 60 · see citing works
Möller, M., Swanepoel, T., & Harvey, B. H. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003368 · Cited by 59 · see citing works
Neuroprotective Effects of Açaí (Euterpe oleracea Mart.) against Rotenone In Vitro Exposure
Machado, A. K., Andreazza, A. C., da Silva, T. M., Boligon, A. A., do Nascimento, V., Scola, G., Duong, A., Cadoná, F. C., Ribeiro, E. E., & da Cruz, I. B. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8940850 · Cited by 60 · see citing works
Mehrpooya, M., Yasrebifar, F., Haghighi, M., Mohammadi, Y., & Jahangard, L. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000938 · Cited by 57 · see citing works
Leukocyte mitochondrial DNA copy number in bipolar disorder
SOUSA, R. T. D., Uno, M., Zanetti, M. V., Oba‐Shinjo, S. M., Busatto, G. F., Gattaz, W. F., Marie, S. K. N., & Machado‐Vieira, R. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.002 · Cited by 57 · see citing works
de Bartolomeis, A., & Tomasetti, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8293-6 · Cited by 57 · see citing works
Brain abnormalities in bipolar disorder detected by quantitative T1ρ mapping
Johnson, C. P., Follmer, R. L., Oğuz, İ., Warren, L. L., Christensen, G. E., Fiedorowicz, J. G., Magnotta, V. A., & Wemmie, J. A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.157 · Cited by 56 · see citing works
- Authors
- Clay, H. B., Daws, S., & Konradi, C.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Konradi, Christine
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2010-09-15
- Volume
- 29
- Issue
- 3
- Pages
- 311-324
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- PMC
- PMC3010320
- OpenAlex
- W2069125243
- Semantic Scholar
- 23e6000158294099c0ba4c2d466d5628d50d089b
- Cited by
- 399
- References
- 189
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 22 · 2023: 25 · 2022: 17 · 2021: 27 · 2020: 22 · 2019: 25 · 2018: 23 · 2017: 28 · 2016: 32 · 2015: 26 · 2014: 36 · 2013: 23 · 2012: 45
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- International Journal of Developmental Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R21MH084131, R01MH067999, MH74000, R01MH074000, MH084131, MH67999)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- mitochondrial dysfunction, bipolar disorder, schizophrenia, mitochondrial respiration, mitochondrial DNA mutations, mtDNA polymorphisms, DNA polymerase gamma, high-energy phosphates, brain pH, brain development, mood disorders, cognitive decline, psychiatric medication, energy metabolism
- MeSH terms
- Animals, Bipolar Disorder, Brain, Calcium, DNA Damage, Energy Metabolism, Humans, Mitochondria, Mutation, Oxidative Phosphorylation, Phenotype, Polymorphism, Genetic, RNA, Messenger, Schizophrenia, Antipsychotic Agents, Apoptosis, Oxidative Stress, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review